<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Behav Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Behav Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Behav. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Behavioral Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28959195</article-id>
<article-id pub-id-type="pmc">5604056</article-id>
<article-id pub-id-type="doi">10.3389/fnbeh.2017.00171</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Prenatal Exposure to Paint Thinner Alters Postnatal Development and Behavior in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Malloul</surname>
<given-names>Hanaa</given-names>
</name>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/452142/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahdani</surname>
<given-names>Ferdaousse M.</given-names>
</name>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/472291/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennis</surname>
<given-names>Mohammed</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/410530/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ba-M’hamed</surname>
<given-names>Saadia</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/389542/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Laboratory of Pharmacology, Neurobiology and Behavior (URAC-37), Faculty of Sciences Semlalia, University Cadi Ayyad</institution>
<country>Marrakech, Morocco</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Nilesh Bhailalbhai Patel, University of Nairobi, Kenya</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Noriyuki Koibuchi, Gunma University, Japan; Valerie J. Bolivar, Wadsworth Center, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Saadia Ba-M’hamed <email xlink:type="simple">bamhamed@uca.ma</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>11</volume>
<elocation-id>171</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Malloul, Mahdani, Bennis and Ba-M’hamed.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Malloul, Mahdani, Bennis and Ba-M’hamed</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Occupational exposure and sniffing of volatile organic solvents continue to be a worldwide health problem, raising the risk for teratogenic sequelae of maternal inhalant abuse. Real life exposures usually involve simultaneous exposures to multiple solvents, and almost all the abused solvents contain a mixture of two or more different volatile compounds. However, several studies examined the teratogenicity due to industrial exposure to a single volatile solvent but investigating the teratogenic potential of complex chemical mixture such as thinner remains unexplored. This study was undertaken to evaluate developmental neurotoxicity of paint thinner using a mouse model. Mated female mice (<italic>N</italic> = 21) were, therefore, exposed to repeated and brief inhalation episodes of 0, 300 or 600 ppm of thinner during the entire period of pregnancy. Females weigh was recorded and their standard fertility and reproductive parameters were assessed. After birth postnatal day 1 (PND1), offspring (<italic>N</italic> = 88) length and body weight were measured in a daily basis. At PND5, the pups were assessed for their postnatal growth, physical maturation, reflex development, neuromotor abilities, sensory function, activity level, anxiety, depression, learning and memory functions. At adulthood, structural changes of the hippocampus were examined by estimating the total volume of the dentate gyrus. Except one case of thinner induced abortion at the higher dose, our results showed that the prenatal exposure to the solvent did not cause any maternal toxicity or decrease in the viability of the offspring. Therefore, a lower birth weight, decrease in the litter size and delayed reflexes ontogeny were registered in prenatally exposed offspring to both 300 ppm and 600 ppm of thinner. In addition, prenatally exposure to thinner resulted in increased anxiolytic- and depression-like behaviors. In contrast, impaired learning and memory functions and decreased hippocampal dentate gyrus volume were revealed only in the prenatally treated offspring by 600 ppm of thinner. Based on these results, we can conclude that prenatally exposure to paint thinner causes a long-lasting developmental neurotoxicity and alters a wide range of behavioral functions in mice. This shows the risk that mothers who abuse thinner paint expose their offspring.</p>
</abstract>
<kwd-group>
<kwd>paint thinner</kwd>
<kwd>prenatal exposure</kwd>
<kwd>fertility</kwd>
<kwd>reproduction</kwd>
<kwd>development</kwd>
<kwd>behavior</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="91"></ref-count>
<page-count count="16"></page-count>
<word-count count="12431"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Paint thinner is a chemical mixture of different aromatic and halogenated hydrocarbons (e.g., toluene, benzene, xylene and N-hexane), commonly used in various industrial applications as solvent in removing household paints and thinning oil-based paint (Solak et al., <xref ref-type="bibr" rid="B74">2006</xref>; Verma and Gomber, <xref ref-type="bibr" rid="B79">2009</xref>; Singh et al., <xref ref-type="bibr" rid="B72">2012</xref>; Agin et al., <xref ref-type="bibr" rid="B3">2016</xref>). Despite its usefulness, there is increasing concern about occupational exposure of industrial workers to this solvent (Yilmaz et al., <xref ref-type="bibr" rid="B90">2001</xref>). In addition, thinner acts as psychoactive compounds when inhaled and its inhalation by young sniffers to achieve an euphoric state continues to be a significant worldwide health problem (Cruz, <xref ref-type="bibr" rid="B23">2011</xref>; Howard et al., <xref ref-type="bibr" rid="B41">2011</xref>; Bowen and Cruz, <xref ref-type="bibr" rid="B15">2012</xref>).</p>
<p>While the volatile substance abuse is documented by diverse groups throughout the world, no epidemiological studies on inhalant abuse in Africa are available. This hampers the estimation of the extent of inhalant abuse across the general population. In the United States alone, the National Survey on Drug Use and Health has documented about 22 million 12 years old Americans and older deliberately abused inhalants at least once in their life from 2002 to 2005 (Substance Abuse and Mental Health Services Administration, <xref ref-type="bibr" rid="B66">2007</xref>). Data show evidence that this abuse of inhalants has dramatically increased over the past years (Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>). From 2009 to 2010, the median age at first use among those aged 12–49 years was unchanged (16.9 and 16.3 years, respectively) with 68.4% being under age of 18 years (Substance Abuse and Mental Health Services Administration, <xref ref-type="bibr" rid="B67">2011</xref>). In 2013, 6.3% of teens in the United States (average age of 19.2 years) reported that the first illicit drug they had ever used was the inhalant (Substance Abuse and Mental Health Services Administration, <xref ref-type="bibr" rid="B68">2014</xref>). Whereas in the past, the abuse of volatile substances was once predominantly limited to males, the gap between males and females is currently reversed: more than 50% of chronic solvents abusers are young women of reproductive age (Substance Abuse and Mental Health Services Administration, <xref ref-type="bibr" rid="B66">2007</xref>; Butland et al., <xref ref-type="bibr" rid="B21">2012</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>). Further, while a subcategory of inhalant abusers continue to do so into adulthood (Williams and Storck, <xref ref-type="bibr" rid="B84">2007</xref>; Substance Abuse and Mental Health Services Administration, <xref ref-type="bibr" rid="B68">2014</xref>), there is increasing concern about the potential negative consequences of deliberately inhaled solvents on the unborn (Bukowski, <xref ref-type="bibr" rid="B20">2001</xref>; Hannigan and Bowen, <xref ref-type="bibr" rid="B34">2010</xref>).</p>
<p>In comparison to inhalant abuse, reports of occupational exposure are not well documented due to potential limitations including small sample size, selection bias, uncontrolled and/or unspecified co-drug exposures and multiple solvent exposures (Hannigan and Bowen, <xref ref-type="bibr" rid="B34">2010</xref>). Standards for a permissible exposure limit (PEL) for toluene have been established by U.S. Occupational Safety and Health Administration (OSHA) at 100 ppm (375 mg/mm<sup>3</sup>, calculated over an 8 h day as a time weighted average; Donald et al., <xref ref-type="bibr" rid="B24">1991</xref>). After acute exposures of at least 500 ppm, a sense of euphoria generally is achieved; inhibition, confusion, incoordination, auditory and visual hallucinations occur at 600–800 ppm (Brozosky and Winkler, <xref ref-type="bibr" rid="B19">1965</xref>). In contrast to chronic low-level (500 ppm) of occupational solvent exposure (Agency for Toxic Substances and Disease Registry (ATSDR) (<xref ref-type="bibr" rid="B2">2000</xref>)), inhalant abusers usually inhale very repeatedly, deeply and rapidly. Therefore, abused toluene minimally reaches 800 ppm, an intoxicating exposure (Filley et al., <xref ref-type="bibr" rid="B27">2004</xref>), although abuse levels in chronic abusers often are higher and exceeding 5000 ppm (50 times the OSHA PEL; Ron, <xref ref-type="bibr" rid="B62">1986</xref>).</p>
<p>In human adults, effects observed after long-term occupational exposures to thinner include dizziness, memory deficits, dementia, depression and fatigue (Kishi et al., <xref ref-type="bibr" rid="B46">1993</xref>; Wang and Chen, <xref ref-type="bibr" rid="B82">1993</xref>; Lee et al., <xref ref-type="bibr" rid="B51">2003</xref>; Bowen et al., <xref ref-type="bibr" rid="B14">2006</xref>). These wide ranges of neurobehavioral symptoms were reported to be due to the cerebral cortical and hippocampal atrophy and to the decreased brain volume observed in solvent abusers (Fornazzari et al., <xref ref-type="bibr" rid="B28">1983</xref>; Lazar et al., <xref ref-type="bibr" rid="B49">1983</xref>; Zur and Yule, <xref ref-type="bibr" rid="B91">1990</xref>; Kamran and Bakshi, <xref ref-type="bibr" rid="B45">1998</xref>). Some of these effects have been reproduced in animal studies. Neonatal exposure to volatile inhalants leads also to persistent impacts on behaviors and brain-structural properties (Benignus, <xref ref-type="bibr" rid="B11">1981</xref>; von Euler et al., <xref ref-type="bibr" rid="B80">1993</xref>, <xref ref-type="bibr" rid="B81">2000</xref>). However, there is a limited amount of literature on teratogenic impact of prenatal exposure to paint thinner.</p>
<p>Placental transfer of toluene and xylene, the largest constituents of thinner mixture (Fifel et al., <xref ref-type="bibr" rid="B26">2014</xref>), has been shown in both humans and rodents (Ghantous and Danielsson, <xref ref-type="bibr" rid="B30">1986</xref>; Goodwin, <xref ref-type="bibr" rid="B31">1988</xref>; Hass et al., <xref ref-type="bibr" rid="B36">1995</xref>). Most studies demonstrated that toluene abuse during pregnancy can result in developmental disabilities and physical anomalies in the offspring (Hersh et al., <xref ref-type="bibr" rid="B39">1985</xref>; Goodwin, <xref ref-type="bibr" rid="B31">1988</xref>; Hersh, <xref ref-type="bibr" rid="B38">1989</xref>; Arnold et al., <xref ref-type="bibr" rid="B7">1994</xref>; Arai et al., <xref ref-type="bibr" rid="B6">1997</xref>). Both clinically and in animal models, maternal exposure to solvents like toluene can lead to fetal or infant death (Wilkins-Haug and Gabow, <xref ref-type="bibr" rid="B83">1991</xref>; Arnold et al., <xref ref-type="bibr" rid="B7">1994</xref>) and a clear evidence of crude morphological teratogenicity was reported in surviving neonates (Ng et al., <xref ref-type="bibr" rid="B55">1992</xref>; Hannigan and Bowen, <xref ref-type="bibr" rid="B34">2010</xref>; Bowen, <xref ref-type="bibr" rid="B12">2011</xref>). The neonates are small for gestational age and microcephalic with distinct dysmorphology (e.g., spatulate fingertips, short palpebral fissures, small face, micrognathia, low-set ears, deep-set eyes and hypoplastic fingernails; Hunter et al., <xref ref-type="bibr" rid="B43">1979</xref>; Toutant and Lippmann, <xref ref-type="bibr" rid="B77">1979</xref>; Hersh et al., <xref ref-type="bibr" rid="B39">1985</xref>; Goodwin, <xref ref-type="bibr" rid="B31">1988</xref>; Hersh, <xref ref-type="bibr" rid="B38">1989</xref>; Arnold et al., <xref ref-type="bibr" rid="B7">1994</xref>). With age, prenatal toluene exposure results in developmental delay and behavioral disruptions (Bukowski, <xref ref-type="bibr" rid="B20">2001</xref>; Hannigan and Bowen, <xref ref-type="bibr" rid="B34">2010</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>).</p>
<p>Almost, all the studies outlined above have evaluated teratogenic potential of a single volatile solvent, toluene or xylene. However, environmental and occupational exposure to solvents involves simultaneous exposure to multiple toxicants. Based hereupon, the aim of our study was to investigate the developmental and neurobehavioral consequences of prenatal exposure to thinner. The present study used a pattern of brief and repeated thinner inhalation during gestation in mice was designed to assess the developmental neurotoxicity of thinner. A battery of behavioral tests was performed to evaluate teratogenic effect of thinner on prenatal and neonatal growth, pre-weaning behavioral development, and adult behaviors; complying with the upcoming OECD Test Guideline for Developmental Neurotoxicity Studies (OECD Test Guideline Programme, <xref ref-type="bibr" rid="B56">1996</xref>).</p>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>Experiments were performed on male and female Swiss mice (8–10 weeks old, weighing 25–30 g) raised in the central animal care facilities of the Cadi Ayyad University, Marrakech (Morocco). Animals were housed in Plexiglas cages with wood chip bedding under controlled environmental conditions (12:12 light/dark cycle, 22 ± 2°C), with standard diet and water <italic>ad libitum</italic>. All animal procedures were in strict accordance with the guidelines of European Council Directive (EU2010/63). All efforts were made to minimize any animal suffering and the study met the ethical standards. The study received also the approval of the Council Committee of research laboratories of the Faculty of Sciences, Cadi Ayyad University of Marrakech.</p>
<p>Virgin female mice (<italic>N</italic> = 21) at proestrus phase were mated with male in the ratio of 2:1 overnight (12 h). The following day, the onset of pregnancy was confirmed by the observation of a vaginal plug. Confirmation of positive sperm-plug corresponded to gestational day 0 (GD0). After mating, the males were removed from the cages and the pregnant females were then assigned to one of three experimental groups in random order.</p>
</sec>
<sec id="s2-2">
<title>Paint Thinner Inhalation</title>
<p>We exposed mice to paint thinner (Sodecso, Mohammedia, Morocco) whose chemical composition, determined by gas chromatography and single wavelength monitoring spectrometry (Chemistry Analysis and Characterization Centre, University Cadi Ayyad) in our previous study (Fifel et al., <xref ref-type="bibr" rid="B26">2014</xref>), includes more than 25 distinct molecules among which the most representative are Toluene (24.46%), Xylene (15.47%), Benzene (10.67%), Dichloromethylene (6.34%) and Acetone (5.55%).</p>
<p>Dams were exposed daily via inhalation to either 300 ppm (<italic>N</italic> = 8) or 600 ppm of thinner (<italic>N</italic> = 5) for the whole period of gestation. An “air-only” control group (<italic>N</italic> = 8) was manipulated for the same period and conditions as the thinner exposure groups, but without thinner (0 ppm). The exposure procedure and apparatus have been described in detail previously (see Fifel et al., <xref ref-type="bibr" rid="B26">2014</xref>). Briefly, a dam was placed into a whole-body inhalation chamber (27 × 17.5 × 13.5 cm) and 200 μl or 400 μl of liquid thinner was added to a filter paper located on a glass petri dish covered by a wire mesh on the inhalation chamber floor to obtain an estimated thinner concentration of 300 ppm or 600 ppm respectively. Exposure to thinner vapor occurred twice a day between (first exposure between 8:00–9:00 a.m. and second exposure 8 h later), two sessions of 15 min (filter paper and liquid thinner were renewed at the beginning of each session), separated by 5 min interval in which mice were returned to the home cage (30 min of one exposure session and 60 min of total daily exposures).</p>
</sec>
<sec id="s2-3">
<title>Maternal Observation</title>
<p>During the whole period of gestation, pregnant mice were observed daily in order to detect any changes in behavior, symptoms of poisoning or signs of morbidity. Abortion or premature delivery and body weight were recorded daily from GD0 until delivery. In addition, different parameters of fertility and reproduction were evaluated as described by Ait-Bali et al. (<xref ref-type="bibr" rid="B4">2016</xref>):</p>
<list list-type="bullet">
<list-item>
<p>Pregnancy index: (number of pregnant females/number of vaginal plug positive females) × 100</p>
</list-item>
<list-item>
<p>Deliverance index: (number of females delivering/number of pregnant female) × 100</p>
</list-item>
<list-item>
<p>Live-birth index : (number of offspring born alive/number of descendants delivered) × 100</p>
</list-item>
<list-item>
<p>Viability index: (number of living offspring at day 4 of lactation/number of living offspring delivered) × 100</p>
</list-item>
<list-item>
<p>Lactation index: (number of living offspring at day 21/number of living offspring born) × 100</p>
</list-item>
</list>
</sec>
<sec id="s2-4">
<title>Birth Measures and Developmental Assessment of the Offspring</title>
<p>At the day of delivery designated as postnatal day 1 (PND1), all pups from each litter (Control: <italic>N</italic> = 22, 300 ppm-treated: <italic>N</italic> = 30, 600 ppm-treated: <italic>N</italic> = 36) were counted, sexed base on the anogenital distance, and checked for apparent morphological anomalies (e.g., facial malformations, missing digits, etc). Litter size and body weight for each pup were measured at PND1, PND7, PND14 and PND21. The appearance of physical maturation landmarks were recorded, including pinna detachment, hair appearance, incisor eruption, and eye opening. In order to not disturb and to minimize the stress on the dam and the offspring, litters were not culled, but litter with less than four pups were not included in the behavioral tests. Subsequently, pups were subjected to the following battery of pre-weaning tests (Table <xref ref-type="table" rid="T1">1</xref>) in order to test reflex development and neuromotor ability (Fox, <xref ref-type="bibr" rid="B29">1965</xref>; Adams, <xref ref-type="bibr" rid="B1">1986</xref>; Moser, <xref ref-type="bibr" rid="B54">2001</xref>). These reflexologic and behavioral tests, reactive to environmental and toxic conditions with greater reliability, were used to assess the maturation of the CNS (Vaglenova et al., <xref ref-type="bibr" rid="B78">2008</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Postnatal behavioral test battery.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Endpoints</th>
<th align="left" colspan="1" rowspan="1">Tests</th>
<th align="left" colspan="1" rowspan="1">Age at testing</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Physical development</td>
<td align="left" colspan="1" rowspan="1">Pinna detachment</td>
<td align="left" colspan="1" rowspan="1">PND4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Hair appearance</td>
<td align="left" colspan="1" rowspan="1">PND6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Incisor eruption</td>
<td align="left" colspan="1" rowspan="1">PND8–12</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Eyes opening</td>
<td align="left" colspan="1" rowspan="1">PND15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sensory-motor development</td>
<td align="left" colspan="1" rowspan="1">Surface righting reflex</td>
<td align="left" colspan="1" rowspan="1">PND5–7–9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Cliff avoidance</td>
<td align="left" colspan="1" rowspan="1">PND6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Homing</td>
<td align="left" colspan="1" rowspan="1">PND9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Negative geotaxis</td>
<td align="left" colspan="1" rowspan="1">PND10–12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Motor coordination</td>
<td align="left" colspan="1" rowspan="1">Rotarod</td>
<td align="left" colspan="1" rowspan="1">PND24</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Motor activity</td>
<td align="left" colspan="1" rowspan="1">Open field</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anxiety</td>
<td align="left" colspan="1" rowspan="1">Open field</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Elevated plus maze</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Depression</td>
<td align="left" colspan="1" rowspan="1">Tail suspension</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Splash</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Learning and memory</td>
<td align="left" colspan="1" rowspan="1">Step-through inhibitory avoidance</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Puzzle box</td>
<td align="left" colspan="1" rowspan="1">PND60</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s2-4-1">
<title>Surface Righting Reflex Test</title>
<p>Each pup was placed in a supine position and the latency to get back on all four paws was calculated. Each pup received one trial and a maximum of 60 s was given in each trail. The maximum latency of 60 s was assigned to the pups that did not right.</p>
</sec>
<sec id="s2-4-2">
<title>Cliff Avoidance Test</title>
<p>Each pup was placed on a table edge with forepaws and snout over the edge. The time spent to turn 180° away from the cliff face was measured and cliff avoidance was recorded for a maximum time of 60 s.</p>
</sec>
<sec id="s2-4-3">
<title>Homing Test</title>
<p>For 30 min in one holding cage, the pups were separated from the dam and kept at a temperature of 35°C. The litter was then transferred to a Plexiglas cage (36 × 20 cm, walls 18 cm high) containing bedding from the home cage evenly distributed on one side (14 × 20 cm, nest area) and the rest of the cage covered with clean wood shavings. Each pup was placed in the middle of the cage and video recorded for 4 min. Homing performance was scored for the time spent in the area with nest litter.</p>
</sec>
<sec id="s2-4-4">
<title>Negative Geotaxis Test</title>
<p>Pups were placed on 45° inclined plywood surface and the time taken to turn 180° from a head-downward position to face-upward was calculated.</p>
</sec>
<sec id="s2-4-5">
<title>Rotarod Test</title>
<p>Rotarod was used to evaluate the ability of mice to remain their balance on revolving rod (15 rpm) during 5 min trial. The apparatus consisted of horizontal textured roller of 3 cm diameter placed at a height of 28 cm with automatic fall detection. All mice underwent two trials with a 15 min inter-trial interval. The latency to fall off was measured for each session. The apparatus was cleaned after each trial. Litters remained with their dams until weaning on PND21 when all offspring were re-housed in groups of five same-sex littermates or other mice from the same prenatal thinner group. All animals were unhandled between PND24 and PND60 when the behavioral tests began.</p>
</sec>
</sec>
<sec id="s2-5">
<title>Adult Neurobehavioral Evaluation</title>
<p>All animals were tested at PND60 (Table <xref ref-type="table" rid="T1">1</xref>). To assess locomotor activity and anxiety-like behaviors, we used the open field test (OFT; Wilson et al., <xref ref-type="bibr" rid="B87">1976</xref>) and the elevated plus maze test (EPMT; Torres and Escarabajal, <xref ref-type="bibr" rid="B76">2002</xref>; Lapiz-Bluhm et al., <xref ref-type="bibr" rid="B48">2008</xref>); depressive-like state of mice was evaluated by means of the tail suspension test (TST; Steru et al., <xref ref-type="bibr" rid="B75">1985</xref>) and Splash test (ST; Willner, <xref ref-type="bibr" rid="B86">2005</xref>; Isingrini et al., <xref ref-type="bibr" rid="B44">2010</xref>); memory retention was assessed by the step-through passive avoidance task (SPAT; Lo et al., <xref ref-type="bibr" rid="B53">2009</xref>), and executive function by the Puzzle box (PB; Ben Abdallah et al., <xref ref-type="bibr" rid="B10">2011</xref>). The OFT and EPMT were recorded and analyzed using Ethovision XT Noldus 8.5 video tracking program (Noldus, Netherlands) connected to a video camera (JVC). The behaviors in TST, ST, SPAT and PB were video-recorded (Samsung SCO-2080R) and measured manually using the event-recording function in the video-tracking software (Debut video capture software, NHC). All the behavioral tests were performed between 8:00 and 12:00 a.m. to avert any circadian related fluctuation in the performance of the animals. Before each mouse was introduced, the apparatus in all behavioral tests cleaned with a 75% ethanol solution to remove any trace of odor.</p>
<sec id="s2-5-1">
<title>Open-Field Test</title>
<p>The apparatus used for this test consisted of a simple square field (50 × 50 × 50 cm). A 75W lamp was placed in porthole diffusing light and located at 200 cm from the device allowing the center of the apparatus to be under a dim light (100 lx). At the beginning of each session, mice were placed in the central part (15 cm × 15 cm) of the arena and the total distance moved, velocity, and the total time spent into center were determined over a 10 min period. The center zone is 17.5 cm from the wall of the maze, corresponding to the standard area (Park et al., <xref ref-type="bibr" rid="B58">2015</xref>).</p>
</sec>
<sec id="s2-5-2">
<title>Elevated Plus Maze Test</title>
<p>The maze composed by two open arms (50 × 5 cm) and two enclosed arms (50 × 5 × 15 cm connected to a common central platform (5 × 5 cm). The maze floor and the side/end walls (15 cm height) of the enclosed arms were made of clear Plexiglas. The apparatus was raised to 50 cm from the floor and was under an approximate brightness of 200 lx. Each mouse was placed in the center facing an open arm and left to explore the maze for a single 5 min recorded session. The percentage of the time spent in the open arms was analyzed by calculating the “time spent in the open arms” divided by the “total time spent in both the open and enclosed arms”.</p>
</sec>
<sec id="s2-5-3">
<title>Tail Suspension Test</title>
<p>Mice were suspended from a plastic rod mounted 50 cm above the surface by fastening the tail with adhesive tape. Immobility, defined as the absence of any limb or body movements, was measured during 6 min.</p>
</sec>
<sec id="s2-5-4">
<title>Splash Test</title>
<p>A 10% sucrose solution was squirted on the dorsal coat of the mouse in its home cage. Because of its viscosity, the sucrose solution dirties the mouse fur and animals initiate grooming behavior. The time spent grooming body, face and paws was recorded after applying sucrose solution for a period of 5 min.</p>
</sec>
<sec id="s2-5-5">
<title>Step-through Passive Avoidance Learning</title>
<p>The step-through inhibitory avoidance apparatus consisted of bright and dark equally sized Plexiglas compartments (28.5 × 25 × 25 cm), with independent electrical grid floor, and connected by an opening guillotine door (10 × 8.5 cm). During the training session, mice were placed individually in the light chamber. Then as soon as the animal entered the dark chamber, the door was lowered and an inescapable single electric foot shock (0.5 mA) was delivered by a shocker for 5 s. Ten seconds after exposure to the foot shock, the animal was removed from the chamber to its home cage. The retention of the avoidance performance was tested 24 h later. With access to the dark chamber, each mouse was placed into the light chamber without any shock during the test session and the latency to enter the dark compartment was calculated. The mice that did not enter the dark chamber during the cut-off time (180 s) were removed from the apparatus and assigned a ceiling score of 180 s. Short latencies indicate poor retention.</p>
</sec>
<sec id="s2-5-6">
<title>Puzzle Box</title>
<p>The Puzzle box is an acrylic Plexiglas arena divided into two areas by a removable barrier: a brightly-lit (300 lx) open-field area (58 × 28 × 21 cm) and a covered goal-box area (15 × 28 × 21 cm). Mice undergo a three-day protocol, consisting of nine trials (T1–T9) with three trials per day and 1.5 h of inter-trial interval, during which they were challenged to enter into the goal zone via a narrow underpass (4 cm wide). This underpass, located under the barrier, was blocked with obstacles that are increasingly difficult to overcome as testing progress. At the beginning of each trail, mouse was placed in the open-field zone facing the goal-box, and the time taken to enter the goal zone with all four paws was recorded over a period of 3 min (training and burrowing) or 4 min (plug). Three obstruction conditions were used within this task:</p>
<list list-type="bullet">
<list-item>
<p>The first day (training): with no obstruction presented within the underpass, and the barrier had an open door between the open-field and goal zones during T1. On T2 and T3, doorway was closed and mouse had to enter the goal zone through the underpass.</p>
</list-item>
<list-item>
<p>The second day (burrowing puzzle): T4 was a repetition of T2 and T3. However, on T5 and T6 the underpass was filled with clean bedding material and mouse had to dig their way through.</p>
</list-item>
<list-item>
<p>The third day (plug puzzle): T7 was a similar to T5 and T6, but on T8 and T9, the underpass was obstructed by a cardboard plug and mouse had to draw with teeth and paws to enter the goal zone.</p>
</list-item>
</list>
<p>The performance of mice in the puzzle box permits to test the capacities of mice to remove the offered barrier in each block. This sequence allow to asses native problem-solving ability (T5 and T8), and learning/ short-term memory (T3, T6 and T9), while the repetition on the next day is used as recall and solution retention to examine the long-term memory (T4 and T7).</p>
</sec>
</sec>
<sec id="s2-6">
<title>Histology and Dentate Gyrus Volume</title>
<p>Upon completion of behavioral testing (Table <xref ref-type="table" rid="T1">1</xref>), mice were deeply anesthetized by an intraperitoneal injection of lethal dose of sodium pentobarbital (&gt;90 mg/kg) and perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were removed from the skull, post-fixed overnight in the same fixative solution, cryoprotected in a 30% sucrose solution, frozen and sectioned by using a freezing microtome (Leica Microsystems, Germany). Forty-micrometer thick free-floating coronal serial sections of the dentate gyrus (DG) were collected in multiwell dishes. Sections were mounted on gelatine-coated slides and stained with Cresyl violet.</p>
<p>With regards to the experimental group, all area counts were conducted blind. To estimate the volume of DG, area measurement of each DG blade were made through sections of the entire DG (positioned at anterior, medial and posterior levels) at low-magnification (×6.3) by using Olympus BH-2 microscope equipped with an Olympus DP71 camera. The reconstruction of a complete photomicrograph association of different shots and their treatment has been made through image processing software Adobe Photoshop CC 2014. The area of each section was calculated by ImageJ software and the total volume of the DG was estimated by applying the Cavalieri method (Prakash et al., <xref ref-type="bibr" rid="B60">1994</xref>). For each animal, 10 DG sections (along the rostrocaudal axis) were used in each analysis.</p>
</sec>
<sec id="s2-7">
<title>Statistical Analysis</title>
<p>Statistical analyses were performed using Prism 5.0 for Windows (GraphPad software). For statistical evaluations of the different dependent variables, one-way analysis of variance (ANOVA) and two-way ANOVA followed by a Bonferroni <italic>post hoc</italic> for multiple comparisons were used. A difference was considered statistically significant at <italic>P</italic> ≤ 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3-1">
<title>Effect of Thinner Exposure on Fertility and Reproduction Parameters of Pregnant Mice</title>
<p>Maternal data for the 21 dams in the three prenatal treatment groups are presented in Table <xref ref-type="table" rid="T2">2</xref>. No clinical signs of toxicity were observed in the dams during the exposure period, except a one case of thinner induced abortion and two cases of preterm births at the higher dose of thinner (600 ppm). There were no significant differences in gestation period and gestation index between the treated groups and the control group (Table <xref ref-type="table" rid="T2">2</xref>). Moreover, Delivery, live-birth, viability and lactation index of treated groups did not differ compared to the control group (Table <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Pregnancy data and maternal characteristics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Parameters</th>
<th align="center" colspan="3" rowspan="1">Thinner (ppm)</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Control</th>
<th align="left" colspan="1" rowspan="1">300</th>
<th align="left" colspan="1" rowspan="1">600</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Fertility parameters</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Number of plug vaginal positive females</td>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Number of pregnant females</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Number of aborted mice</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Pregnancy index (%)</td>
<td align="left" colspan="1" rowspan="1">80</td>
<td align="left" colspan="1" rowspan="1">61.53</td>
<td align="left" colspan="1" rowspan="1">55.55</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Gestation period (days)</td>
<td align="left" colspan="1" rowspan="1">19.05 ± 1.92</td>
<td align="left" colspan="1" rowspan="1">18.75 ± 1.03</td>
<td align="left" colspan="1" rowspan="1">18.01 ± 0.60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Reproduction parameters</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Deliverance index (%)</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">80</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Live-birth index (%)</td>
<td align="left" colspan="1" rowspan="1">95.55</td>
<td align="left" colspan="1" rowspan="1">90</td>
<td align="left" colspan="1" rowspan="1">72.55</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Viability index (%)</td>
<td align="left" colspan="1" rowspan="1">68.57</td>
<td align="left" colspan="1" rowspan="1">66.03</td>
<td align="left" colspan="1" rowspan="1">65.31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Lactation index (%)</td>
<td align="left" colspan="1" rowspan="1">68.18</td>
<td align="left" colspan="1" rowspan="1">60.37</td>
<td align="left" colspan="1" rowspan="1">51.72</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Number of pups/litter</td>
<td align="left" colspan="1" rowspan="1">7.01 ± 2.34</td>
<td align="left" colspan="1" rowspan="1">6.62 ± 2.66</td>
<td align="left" colspan="1" rowspan="1">8 ± 1.50</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Maternal weight (g)</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Weight gain at GD7</td>
<td align="left" colspan="1" rowspan="1">2.69 ± 1.30</td>
<td align="left" colspan="1" rowspan="1">2.79 ± 1.47</td>
<td align="left" colspan="1" rowspan="1">2.17 ± 1.25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Weight gain at GD15</td>
<td align="left" colspan="1" rowspan="1">8.09 ± 2.34</td>
<td align="left" colspan="1" rowspan="1">6.32 ± 1.91</td>
<td align="left" colspan="1" rowspan="1">5.28 ± 2.15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Weight gain at GD18</td>
<td align="left" colspan="1" rowspan="1">11.04 ± 3.05</td>
<td align="left" colspan="1" rowspan="1">9.21 ± 3.65</td>
<td align="left" colspan="1" rowspan="1">7.01 ± 2.40*</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Weight gain between GD0–GD18</td>
<td align="left" colspan="1" rowspan="1">21.62 ± 2.81</td>
<td align="left" colspan="1" rowspan="1">16.08 ± 2.65***</td>
<td align="left" colspan="1" rowspan="1">14.34 ± 1.91***</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data are given as means ± SD. *P &lt; 0.05 and ***P &lt; 0.001 compared to control</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Concerning the body weight of pregnant females, the statistical analysis by two-way ANOVA was performed between-subject variables: treatment and gestation duration. This analysis showed a significant effect of treatment (<italic>F</italic><sub>(2,72)</sub> = 15.79, <italic>P</italic> &lt; 0.001) and gestation period (<italic>F</italic><sub>(3,72)</sub> = 135.2, <italic>P</italic> &lt; 0.001) on dam weights. Bonferroni <italic>post hoc</italic> analyses revealed that dams exposed to 600 ppm of thinner gained significantly less weight than the control at GD18 (<italic>t</italic> = 2.95, <italic>P</italic> &lt; 0.05); otherwise, there was a significant less weight gain for dams in all treated groups compared to control group from GD0 to GD18 (control group vs. 300 ppm group: <italic>t</italic> = 4.61, <italic>P</italic> &lt; 0.001; control group vs. 600 ppm group: <italic>t</italic> = 5.31, <italic>P</italic> &lt; 0.001; 300 ppm group vs. 600 ppm group: <italic>t</italic> = 1.12, NS).</p>
</sec>
<sec id="s3-2">
<title>Effect of Prenatal Exposure to Thinner on Physical Development</title>
<sec id="s3-2-1">
<title>Morphological Evaluation</title>
<p>By using a comparative atlas of external malformations in laboratory animals and humans (Roux, <xref ref-type="bibr" rid="B63">2003</xref>), each pup was observed for signs of malformations and abnormal morphological changes. No obvious external malformations were noted in the three prenatal treatment groups.</p>
</sec>
<sec id="s3-2-2">
<title>Body Weights of Pups</title>
<p>A two-way ANOVA analysis was performed considering treatment and age as main factors. Our results indicated a significant effect of treatment, age of the pups and the interaction of these two factors on body weight (<italic>F</italic><sub>(2,288)</sub> = 83.35, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(3,288)</sub> = 378.70, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(6,288)</sub> = 9.53, <italic>P</italic> &lt; 0.001; respectively). While no significant main effects were observed for thinner prenatal exposure on PND1 body weight for all pups (<italic>P</italic> &gt; 0.50, NS), Bonferroni <italic>post hoc</italic> analysis showed that there was a significant loss in the body weight of prenatally treated offspring compared to the control at PND7 (<italic>t</italic> = 0.67, NS; <italic>t</italic> = 5.71, <italic>P</italic> &lt; 0.001; respectively), PND14 (<italic>t</italic> = 3.03, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 7.29, <italic>P</italic> &lt; 0.001; respectively), and PND21 (<italic>t</italic> = 4.18, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 10.44, <italic>P</italic> &lt; 0.001; respectively). Additionally, 600 ppm pretreated group also weighs less than 300 ppm pretreated group at PND7 (<italic>t</italic> = 5.46, <italic>P</italic> &lt; 0.001), PND14 (<italic>t</italic> = 4.78, <italic>P</italic> &lt; 0.001), and PND12 (<italic>t</italic> = 6.99, <italic>P</italic> &lt; 0.001; Table <xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Litter and offspring characteristics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Parameters</th>
<th align="center" colspan="3" rowspan="1">Thinner (ppm)</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Control</th>
<th align="left" colspan="1" rowspan="1">300</th>
<th align="left" colspan="1" rowspan="1">600</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Offspring body weight (g)</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body weight at PND1</td>
<td align="left" colspan="1" rowspan="1">1.51 ± 0.23</td>
<td align="left" colspan="1" rowspan="1">1.58 ± 0.58</td>
<td align="left" colspan="1" rowspan="1">1.31 ± 0.25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body weight at PND7</td>
<td align="left" colspan="1" rowspan="1">4.90 ± 1.02</td>
<td align="left" colspan="1" rowspan="1">4.71 ± 1.04</td>
<td align="left" colspan="1" rowspan="1">3.11 ± 1.20***<sup>###</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body weight at PND14</td>
<td align="left" colspan="1" rowspan="1">6.80 ± 1.03</td>
<td align="left" colspan="1" rowspan="1">5.91 ± 1.45**</td>
<td align="left" colspan="1" rowspan="1">4.51 ± 1.21***<sup>###</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body weight at PND21</td>
<td align="left" colspan="1" rowspan="1">8.56 ± 2.01</td>
<td align="left" colspan="1" rowspan="1">7.32 ± 0.07***</td>
<td align="left" colspan="1" rowspan="1">5.27 ± 1.15***<sup>###</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Offspring body length (cm)</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body length at PND1</td>
<td align="left" colspan="1" rowspan="1">4.15 ± 0.39</td>
<td align="left" colspan="1" rowspan="1">4.27 ± 0.33</td>
<td align="left" colspan="1" rowspan="1">3.89 ± 0.39</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body length at PND7</td>
<td align="left" colspan="1" rowspan="1">7.24 ± 0.34</td>
<td align="left" colspan="1" rowspan="1">6.81 ± 0.61</td>
<td align="left" colspan="1" rowspan="1">6.40 ± 0.75***</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body length at PND14</td>
<td align="left" colspan="1" rowspan="1">8.57 ± 0.28</td>
<td align="left" colspan="1" rowspan="1">8.54 ± 0.21</td>
<td align="left" colspan="1" rowspan="1">7.54 ± 1.13***<sup>###</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Body length at PND21</td>
<td align="left" colspan="1" rowspan="1">10.94 ± 0.86</td>
<td align="left" colspan="1" rowspan="1">10.53 ± 0.69</td>
<td align="left" colspan="1" rowspan="1">8.69 ± 1.38***<sup>###</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Litter sex ratio (% males)</bold>
</td>
<td align="left" colspan="1" rowspan="1">52.82 ± 0.59</td>
<td align="left" colspan="1" rowspan="1">58.73 ± 0.39</td>
<td align="left" colspan="1" rowspan="1">62.48 ± 0.33</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Developmental landmarks (%)</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Pinna detachment at PND4</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">90</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Hair appearance at PND6</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">90</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Eruption of lower incisors at PND8</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Eruption of upper incisors at PND12</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">    Eyes opening at PND15</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">88.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data are given as means ± SD. **P &lt; 0.01 and ***P &lt; 0.001 compared to control. <sup>###</sup>P &lt; 0.001 compared to treated group</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2-3">
<title>Body Length of Pups</title>
<p>There was a significant main effect of thinner exposure on body length of pups revealed by two way ANOVA analysis with treatment and age as factors (treatment: <italic>F</italic><sub>(2,288)</sub> = 51.52, <italic>P</italic> &lt; 0.001; age: <italic>F</italic><sub>(3,288)</sub> = 694.30, <italic>P</italic> &lt; 0.001; treatment × age: <italic>F</italic><sub>(6,288)</sub> = 7.64, <italic>P</italic> &lt; 0.001). <italic>Post hoc</italic> analysis showed that no significant main effects were found for 300 ppm prenatal inhalation on body length compared to control from PND1 to PND21 (Table <xref ref-type="table" rid="T3">3</xref>). However, prenatal exposure to 600 ppm of thinner led to a decrease in body length at PND7 (600 ppm vs. control: <italic>t</italic> = 3.95, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm: <italic>t</italic> = 1.98, NS), PND14 (600 ppm vs. control: <italic>t</italic> = 4.28, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm: <italic>t</italic> = 4.36, <italic>P</italic> &lt; 0.001) and PND21 (600 ppm vs. control: <italic>t</italic> = 9.16, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm: <italic>t</italic> = 8.22, <italic>P</italic> &lt; 0.001); no significant difference was observed at PND1 (Table <xref ref-type="table" rid="T3">3</xref>).</p>
</sec>
<sec id="s3-2-4">
<title>Body Development</title>
<p>As reported in Table <xref ref-type="table" rid="T3">3</xref>, no significant changes in indices of postnatal maturation were noted for pinna unfolding, hair appearance, incisor eruption, or age of eyes opening for thinner-treated animals compared to control-treated animals.</p>
</sec>
</sec>
<sec id="s3-3">
<title>Effect of Prenatal Exposure to Thinner on Sensorimotor Development</title>
<sec id="s3-3-1">
<title>Surface Righting Reflex Test</title>
<p>Data analysis by two-way ANOVA, with treatment and gender as main factors, revealed that surface righting time was significantly affected by treatment at PND5, PND7 and PND9 (<italic>F</italic><sub>(2,64)</sub> = 19.87, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,64)</sub> = 23.25, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,64)</sub> = 61.56, <italic>P</italic> &lt; 0.001; respectively), while the sex (<italic>F</italic><sub>(1,64)</sub> = 1.48, <italic>P</italic> = 0.23; <italic>F</italic><sub>(1,64)</sub> = 0.34, <italic>P</italic> = 0.56; <italic>F</italic><sub>(1,64)</sub> = 1.07, <italic>P</italic> = 0.30; respectively) and interaction of treatment and sex (<italic>F</italic><sub>(2,64)</sub> = 0.03, <italic>P</italic> = 0.97; <italic>F</italic><sub>(2,64)</sub> = 0.29, <italic>P</italic> = 0.75; <italic>F</italic><sub>(2,64)</sub> = 0.06, <italic>P</italic> = 0.95; respectively) had no effect. To analyze more specifically the effects in both sexes of the maternal exposure to thinner, we tested the male and female data separately with two-way ANOVA by using treatment and age as main factors. The statistical analysis showed a significant main effect of treatment and age as shown by the improved surface righting times of animals between PND5 and PND9 [males (<italic>F</italic><sub>(2,114)</sub> = 47.13, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,114)</sub> = 53.78, <italic>P</italic> &lt; 0.001; respectively); females (<italic>F</italic><sub>(2,78)</sub> = 45.70, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,78)</sub> = 48.33, <italic>P</italic> &lt; 0.001; respectively)]. Maternal exposure to 600 ppm delayed significantly the development of offspring righting reflex compared to control and 300 ppm prenatally exposed pups at PND5 [males (<italic>t</italic> = 4.28, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 3.48, <italic>P</italic> &lt; 0.01; respectively); females (<italic>t</italic> = 4.12, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 3.96, <italic>P</italic> &lt; 0.01; respectively)], PND7 [males (<italic>t</italic> = 3.51, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 5.21, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 3.52, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 4.54, <italic>P</italic> &lt; 0.001; respectively)] and PND9 [males (<italic>t</italic> = 7.28, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 6.59, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 7.22, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 7.68, <italic>P</italic> &lt; 0.001; respectively)] (Figure <xref ref-type="fig" rid="F1">1A</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Effect of prenatal exposure to thinner on sensory-motor development. <bold>(A)</bold> Surface righting reflex at PND5, PND7 and PND9. <bold>(B)</bold> Cliff avoidance reflex at PND6. <bold>(C)</bold> Olfactory discrimination at PND9. <bold>(D)</bold> Negative geotaxis reflex at PND10 and PND12. <bold>(E)</bold> Motor coordination at PND24. Results are presented as mean ± SEM (Males: <italic>N</italic> = 13–14, Females: <italic>N</italic> = 8–11). **<italic>P</italic> &lt; 0.01 and ***<italic>P</italic> &lt; 0.001 in comparison with control group. <sup>##</sup><italic>P</italic> &lt; 0.01 and <sup>###</sup><italic>P</italic> &lt; 0.001 in comparison with treated group.</p>
</caption>
<graphic xlink:href="fnbeh-11-00171-g0001"></graphic>
</fig>
</sec>
<sec id="s3-3-2">
<title>Cliff Avoidance Test</title>
<p>A significant main effect of prenatal thinner exposure was found on neonatal reflexes, as evaluated by cliff avoidance [males (<italic>F</italic><sub>(2,38)</sub> = 150.9, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,26)</sub> = 22.94, <italic>P</italic> &lt; 0.001)]. Six hundred parts per million pretreated males and females mice take more time to avoid the cliff than controls and 300 ppm pretreated mice at PND6 [males (<italic>t</italic> = 15.76, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 14.09, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 5.78, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 5.89, <italic>P</italic> &lt; 0.001; respectively)] (Figure <xref ref-type="fig" rid="F1">1B</xref>). Moreover, a two-way ANOVA analysis was performed considering treatment and sex as main factors. This analysis revealed that cliff avoidance time was significantly affected by treatment, sex and the interaction of these two factors (<italic>F</italic><sub>(2,64)</sub> = 116.2, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(1,64)</sub> = 5.80, <italic>P</italic> &lt; 0.05; <italic>F</italic><sub>(2,64)</sub> = 3.54, <italic>P</italic> &lt; 0.05; respectively).</p>
</sec>
<sec id="s3-3-3">
<title>Homing Test</title>
<p>The results showed that the prenatally treated mice presented a retardation in general development in the homing test at PND9 [males (<italic>F</italic><sub>(2,38)</sub> = 42.55, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,26)</sub> = 14.66, <italic>P</italic> &lt; 0.001)] (Figure <xref ref-type="fig" rid="F1">1C</xref>), where a decreased time spent in the nest area was observed with respect to control in both sexes [males (300 ppm vs. control: <italic>t</italic> = 7.21, <italic>P</italic> &lt; 0.001; 600 ppm vs. control: <italic>t</italic> = 8.55, <italic>P</italic> &lt; 0.001); females (300 ppm vs. control: <italic>t</italic> = 3.99, <italic>P</italic> &lt; 0.01; 600 ppm vs. control: <italic>t</italic> = 5.28, <italic>P</italic> &lt; 0.001)]. Therefore, there is a significant effect only between groups (<italic>F</italic><sub>(2,64)</sub> = 51.91, <italic>P</italic> &lt; 0.001) independently of sex.</p>
</sec>
<sec id="s3-3-4">
<title>Negative Geotaxis Test</title>
<p>A two way ANOVA analyses with treatment and sex as factors showed that the performance of mice was affected significantly by the experimental group independently of sex at PND10 and PND12 (<italic>F</italic><sub>(2,64)</sub> = 150.3, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,64)</sub> = 37.41, <italic>P</italic> &lt; 0.001; respectively). To obtain more information about the effect of treatment with the age in each sex, we applied two-way ANOVA considering treatment and age as main factors. There was a significant overall main effect of prenatal thinner treatment, age and the interaction of these two factors in the negative geotaxis test [males (<italic>F</italic><sub>(2,76)</sub> = 110.5, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(1,76)</sub> = 34.88, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,76)</sub> = 19.27, <italic>P</italic> &lt; 0.001; respectively); females (<italic>F</italic><sub>(2,52)</sub> = 64.53, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(1,52)</sub> = 19.05, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(2,52)</sub> = 5.53, <italic>P</italic> &lt; 0.01; respectively)]. All prenatally 600 ppm treated pups reduced their latencies to turn 180° in comparison with control and 300 ppm pretreated animals at PND10 [males (<italic>t</italic> = 12.41, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 13.21, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 8.71, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 9.07, <italic>P</italic> &lt; 0.001; respectively)] and PND12 [males (<italic>t</italic> = 4.36, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 6.13, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 4.47, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 5.75, <italic>P</italic> &lt; 0.001; respectively)] (Figure <xref ref-type="fig" rid="F1">1D</xref>).</p>
</sec>
<sec id="s3-3-5">
<title>Rotarod Test</title>
<p>The two-way ANOVA analysis revealed that the motor coordination was significantly affected by the trial in both sexes [males (<italic>F</italic><sub>(1,76)</sub> = 8.86, <italic>P</italic> &lt; 0.01); females (<italic>F</italic><sub>(1,52)</sub> = 5.83, <italic>P</italic> &lt; 0.05)], while the treatment [males (<italic>F</italic><sub>(2,76)</sub> = 0.76, <italic>P</italic> = 0.47); females (<italic>F</italic><sub>(2,52)</sub> = 2.06, <italic>P</italic> = 0.14)] and interaction of treatment and trial [males (<italic>F</italic><sub>(2,76)</sub> = 1.38, <italic>P</italic> = 0.26); females (<italic>F</italic><sub>(2,52)</sub> = 0.43, <italic>P</italic> = 0.65)] had no effect. At PND24, our results of Rotarod test showed that no significant differences were observed between exposed and control offspring in the fall latency at trial1 [males (300 ppm vs. control: <italic>t</italic> = 0.08, NS; 600 ppm vs. control: <italic>t</italic> = 0.91, NS); females (300 ppm vs. control: <italic>t</italic> = 1.09, NS; 600 ppm vs. control: <italic>t</italic> = 1.39, NS)] and trail2 [males (300 ppm vs. control: <italic>t</italic> = 2.31, NS; 600 ppm vs. control: <italic>t</italic> = 0.65, NS); females (300 ppm vs. control: <italic>t</italic> = 1.71, NS; 600 ppm vs. control: <italic>t</italic> = 0.75, NS)] (Figure <xref ref-type="fig" rid="F1">1E</xref>).</p>
</sec>
</sec>
<sec id="s3-4">
<title>Effect of Prenatal Exposure to Thinner on Adults Behaviors</title>
<p>At PND60, the boy weight was significantly less in female (control = 24.72 ± 1.11 g; 300 ppm = 24.40 ± 1.11 g; 600 ppm = 23.72 ± 1.12 g) than male mice (control = 29.24 ± 1.03 g; 300 ppm = 27.47 ± 1.07 g; 600 ppm = 27.78 ± 1.03 g). The two way ANOVA analysis show that the difference was only significant between sexes (<italic>F</italic><sub>(1,76)</sub> = 19.349, <italic>p</italic> &lt; 0.001), whereas the treatment and interaction sex × treatment have no effect on pups body weight (<italic>F</italic><sub>(2,76)</sub> = 0.76; <italic>p</italic> = 0, 472; <italic>F</italic><sub>(1,76)</sub> = 0.23; <italic>P</italic> = 0.79; respectively).</p>
<sec id="s3-4-1">
<title>Locomotor Activity</title>
<p>Open-field analysis quantified overall locomotor activity showed that mice exposed prenatally to thinner displayed no differences in distance moved from non-exposed controls in both sexes [males (<italic>F</italic><sub>(2,38)</sub> = 1.12, <italic>P</italic> = 0.33); females (<italic>F</italic><sub>(2,26)</sub> = 0.67, <italic>P</italic> = 0.52)] (Figure <xref ref-type="fig" rid="F2">2A</xref>). However, there was a significant main effect of prenatal thinner treatment on the speed of movements only in females [males (<italic>F</italic><sub>(2,38)</sub> = 0.11, <italic>P</italic> = 0.89); females (<italic>F</italic><sub>(2,26)</sub> = 6.79, <italic>P</italic> &lt; 0.01)]; <italic>Post hoc</italic> analyses revealed that the 600 ppm dose group of females showed a significant decrease in velocity over the 10 min compared to 300 ppm dose group (<italic>t</italic> = 3.69, <italic>P</italic> &lt; 0.01). Otherwise, the velocity did not differ between both prenatally exposed females and controls (Figure <xref ref-type="fig" rid="F2">2B</xref>). On the other hand, two way ANOVA analyses revealed that treatment, sex and the interaction treatment × sex had no significant effects on the speed of movements (<italic>F</italic><sub>(2,64)</sub> = 2.22, <italic>P</italic> = 0.07; <italic>F</italic><sub>(1,64)</sub> = 0.25, <italic>P</italic> = 0.61; <italic>F</italic><sub>(2,64)</sub> = 0.08, NS; respectively).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Effect of prenatal exposure to thinner on locomotor activity and anxiety-like behavior. <bold>(A)</bold> Total distance moved in the open field. <bold>(B)</bold> Moving velocity in the open field. <bold>(C)</bold> Ratio time spent in center of the open field. <bold>(D)</bold> Ratio time spent in open arms of the elevated plus maze. Results are presented as mean ± SEM (Males: <italic>N</italic> = 13–14, Females: <italic>N</italic> = 8–11). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01 and ***<italic>P</italic> &lt; 0.001 in comparison with control. <sup>##</sup><italic>P</italic> &lt; 0.01 and <sup>###</sup><italic>P</italic> &lt; 0.001 in comparison with treated group.</p>
</caption>
<graphic xlink:href="fnbeh-11-00171-g0002"></graphic>
</fig>
</sec>
<sec id="s3-4-2">
<title>Anxiety</title>
<p>Anxiety-like traits were evaluated after prenatal thinner exposure using the OF and EPMTs (Figures <xref ref-type="fig" rid="F2">2C,D</xref>). Thinner prenatal exposure seems to cause a significant less anxiety-like behaviors in both sexes as revealed by long time spent in center of open field [males (<italic>F</italic><sub>(2,38)</sub> = 34.20, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,26)</sub> = 9.86, <italic>P</italic> &lt; 0.001)] (Figure <xref ref-type="fig" rid="F2">2C</xref>) and open arms of elevated plus maze [males (<italic>F</italic><sub>(2,38)</sub> = 29.62, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,26)</sub> = 10.72, <italic>P</italic> &lt; 0.001)] (Figure <xref ref-type="fig" rid="F2">2D</xref>). Furthermore, Bonferroni <italic>post hoc</italic> analysis showed that 300 ppm and 600 ppm dose groups spent significantly more time in the center of open field [males (<italic>t</italic> = 5.95, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 7.93, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 3.37, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 4.29, <italic>P</italic> &lt; 0.001; respectively)] and the open arms of elevated plus maze [males (<italic>t</italic> = 2.79, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 7.62, <italic>P</italic> &lt; 0.001; respectively); females (<italic>t</italic> = 2.79, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 4.63, <italic>P</italic> &lt; 0.001; respectively)] compared to control group. Moreover, a significant difference was revealed between prenatally treated groups of males in EPMT (<italic>t</italic> = 4.68, <italic>P</italic> &lt; 0.001). In addition, the two-way ANOVA revealed that the anxiety-like behavior of mice was affected significantly by the experimental group in OFT (<italic>F</italic><sub>(2,64)</sub> = 38.65, <italic>P</italic> &lt; 0.001) and EPMT (<italic>F</italic><sub>(2,64)</sub> = 36.18, <italic>P</italic> &lt; 0.001) independently of sex.</p>
</sec>
<sec id="s3-4-3">
<title>Depression</title>
<p>Tail suspension test and splash test have been used to assess depression-like behavior after prenatal thinner exposure (Figures <xref ref-type="fig" rid="F3">3A,B</xref>). In tail suspension test, treated mice showed a dose dependant increase in the time of immobility compared to the control mice in both sexes [males (one-way ANOVA: <italic>F</italic><sub>(2,38)</sub> = 64.83, <italic>P</italic> &lt; 0.001; Bonferroni <italic>post hoc</italic>: 300 ppm vs. control, <italic>t</italic> = 3.47, <italic>P</italic> &lt; 0.01; 600 ppm vs. control, <italic>t</italic> = 11.15, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm, <italic>t</italic> = 7.48, <italic>P</italic> &lt; 0.001); females (one-way ANOVA: <italic>F</italic><sub>(2,26)</sub> = 31.09, <italic>P</italic> &lt; 0.001; Bonferroni <italic>post hoc</italic>: 300 ppm vs. control, <italic>t</italic> = 4.03, <italic>P</italic> &lt; 0.01; 600 ppm vs. control, <italic>t</italic> = 7.87, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm, <italic>t</italic> = 4.26, <italic>P</italic> &lt; 0.001)] (Figure <xref ref-type="fig" rid="F3">3A</xref>). Similarly, thinner-treated groups as compared to control group exhibited a shorter duration of grooming during splash test in both sexes [males (one-way ANOVA: <italic>F</italic><sub>(2,38)</sub> = 60.62, <italic>P</italic> &lt; 0.001; Bonferroni <italic>post hoc</italic>: 300 ppm vs. control, <italic>t</italic> = 6.89, <italic>P</italic> &lt; 0.001; 600 ppm vs. control, <italic>t</italic> = 10.86, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm, <italic>t</italic> = 3.77, <italic>P</italic> &lt; 0.01); females (one-way ANOVA: <italic>F</italic><sub>(2,26)</sub> = 26.96, <italic>P</italic> &lt; 0.001; Bonferroni <italic>post hoc</italic>: 300 ppm vs. control, <italic>t</italic> = 4.99, <italic>P</italic> &lt; 0.001; 600 ppm vs. control, <italic>t</italic> = 7.27, <italic>P</italic> &lt; 0.001; 600 ppm vs. 300 ppm, <italic>t</italic> = 2.59, <italic>P</italic> &lt; 0.05)] (Figure <xref ref-type="fig" rid="F3">3B</xref>). Moreover, depression-like response was affected significantly by treatment and sex in tail suspension test (<italic>F</italic><sub>(2,64)</sub> = 96.34, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(1,64)</sub> = 8.29, <italic>P</italic> &lt; 0.01; respectively) and splash test (<italic>F</italic><sub>(2,64)</sub> = 84.77, <italic>P</italic> &lt; 0.001; <italic>F</italic><sub>(1,64)</sub> = 8.14, <italic>P</italic> &lt; 0.01; respectively) as revealed by two-way ANOVA analyses.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Effect of prenatal exposure to thinner on depression-like behavior, memory retention and executive function. <bold>(A)</bold> Time of immobility measured during tail suspension test. <bold>(B)</bold> Grooming time calculated during splash test. <bold>(C)</bold> Latency to enter the dark chamber calculated during step-through inhibitory avoidance test. <bold>(D,E)</bold> Latency scored to reach the goal zone of males and females during the nine trials of the Puzzle box test. Results are presented as mean ± SEM (Males: <italic>N</italic> = 13–14, Females: <italic>N</italic> = 8–11). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01 and ***<italic>P</italic> &lt; 0.001 in comparison with control group. <sup>#</sup><italic>P</italic> &lt; 0.05, <sup>##</sup><italic>P</italic> &lt; 0.01 and <sup>###</sup><italic>P</italic> &lt; 0.001 in comparison with treated group.</p>
</caption>
<graphic xlink:href="fnbeh-11-00171-g0003"></graphic>
</fig>
</sec>
<sec id="s3-4-4">
<title>Learning and Memory</title>
<p>We further examined mice by step-through avoidance learning and puzzle box tasks which have been recognized as useful experimental paradigms for assessing learning, memory retention and executive function (Figures <xref ref-type="fig" rid="F3">3C–E</xref>). In step-through inhibitory avoidance test (Figure <xref ref-type="fig" rid="F3">3C</xref>), there is significant effect of treatment (<italic>F</italic><sub>(2,64)</sub> = 18.47, <italic>P</italic> &lt; 0.001), while the sex (<italic>F</italic><sub>(1,64)</sub> = 1.32, <italic>P</italic> = 0.25) and their interaction (<italic>F</italic><sub>(2,64)</sub> = 0.88, <italic>P</italic> = 0.42) did not affect the latency to step-through as shown by two-way ANOVA analyses. Then, analyses of the male and female data separately with one-way ANOVA revealed that the prenatal thinner exposure affect the latency to step-through during the memory retention test session in both sexes [males (<italic>F</italic><sub>(2,38)</sub> = 13.50, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,26)</sub> = 7.99, <italic>P</italic> &lt; 0.01)]; therefore, in 600 ppm dose groups, there was a significant decrease in step-through latency compared to control group and 300 ppm dose groups [males (<italic>t</italic> = 4.82, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 4.05, <italic>P</italic> &lt; 0.001, respectively); females (<italic>t</italic> = 3.01, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 3.76, <italic>P</italic> &lt; 0.01, respectively)].</p>
<p>Figures <xref ref-type="fig" rid="F3">3D,E</xref> illustrate the time taken to enter the goal box in thinner-treated and control males and females mice among all trials (T1–T9) of puzzle box. Two way ANOVA showed a main effect in both sexes of treatment [males (<italic>F</italic><sub>(2,342)</sub> = 72.34, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(2,234)</sub> = 40.22, <italic>P</italic> &lt; 0.001)], trials [males (<italic>F</italic><sub>(8,342)</sub> = 45.35, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(8,234)</sub> = 31.82, <italic>P</italic> &lt; 0.001)] and their interaction [males (<italic>F</italic><sub>(16,342)</sub> = 7.48, <italic>P</italic> &lt; 0.001); females (<italic>F</italic><sub>(16,234)</sub> = 5.66, <italic>P</italic> &lt; 0.001)]. Mice of all groups similarly learned the puzzle task at the first day (T1–T3) and T4 as shown by their improved latencies on the repeated trials. Further, <italic>post hoc</italic> analysis displayed that all 600 ppm pre-exposed males and females mice spend more time to solve the obstacles in comparison with control and 300 ppm pre-exposed mice at T5 [males (<italic>t</italic> = 2.88, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 2.66, <italic>P</italic> &lt; 0.05, respectively); females (<italic>t</italic> = 2.05, NS; <italic>t</italic> = 3.53, <italic>P</italic> &lt; 0.01, respectively)], T6 [males (<italic>t</italic> = 9.34, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 6.76, <italic>P</italic> &lt; 0.001, respectively); females (<italic>t</italic> = 6.21, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 4.76, <italic>P</italic> &lt; 0.001, respectively)], T7 [males (<italic>t</italic> = 18.38, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 16.50, <italic>P</italic> &lt; 0.001, respectively); females (<italic>t</italic> = 6.66, <italic>P</italic> &lt; 0.001; <italic>t</italic> = 5.35, <italic>P</italic> &lt; 0.001, respectively)], T8 [males (<italic>t</italic> = 2.66, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 2.68, <italic>P</italic> &lt; 0.05, respectively); females (<italic>t</italic> = 0.37, NS; <italic>t</italic> = 2.94, <italic>P</italic> &lt; 0.05, respectively)] and T9 [males (<italic>t</italic> = 3.19, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 3.36, <italic>P</italic> &lt; 0.01, respectively); females (<italic>t</italic> = 2.93, <italic>P</italic> &lt; 0.05; <italic>t</italic> = 3.74, <italic>P</italic> &lt; 0.01, respectively)].</p>
</sec>
</sec>
<sec id="s3-5">
<title>Evaluation of DG Volume after Prenatal Exposure to Thinner</title>
<p>Cresyl violet-stained sections at the same Bregma levels, showed an important reduction in the entire volume of the hippocampus following prenatal exposure to paint thinner. The observed changes were more prominent with 600 ppm than those observed in 300 ppm and control (Figures <xref ref-type="fig" rid="F4">4A–C</xref>). Indeed, the analysis of the dentate gyrus volume of the hippocampus subregions by using the Cavalieri method showed a significant main effect (<italic>F</italic><sub>(2,6)</sub> = 18.33, <italic>P</italic> &lt; 0.01). Moreover, statistical analysis among the different experimental groups revealed that the volume of DG is sharply reduced only in the 600 ppm pre-exposed mice in comparison with control and 300 ppm pre-exposed mice (<italic>t</italic> = 5.14, <italic>P</italic> &lt; 0.01; <italic>t</italic> = 5.33, <italic>P</italic> &lt; 0.01; respectively). Conversely, mice that were prenatally exposed to 300 ppm of thinner displayed no differences in the volume of DG as compared to control mice (<italic>t</italic> = 0.18, NS; Figure <xref ref-type="fig" rid="F4">4D</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Impact of prenatal exposure to thinner on dentate gyrus volume. <bold>(A–C)</bold> Photomicrographs of dentate gyrus (DG) sections stained with Cresyl violet form control and prenatally treated animals by 300 ppm and 600 ppm of thinner at Bregma sections −2.18 mm. <bold>(A’)</bold> Photomicrograph of DG section under high magnification. <bold>(D)</bold> Unusual DG volume was observed in prenatally treated mice by 600 ppm of thinner. Scale bars in <bold>(A–C,A’)</bold> are 100 μm. Results are presented as mean ± SEM (<italic>N</italic> = 5). **<italic>P</italic> &lt; 0.01 in comparison with control group and <sup>##</sup><italic>P</italic> &lt; 0.01 in comparison with treated group. ML, Molecular layer; GCL, granule cell layer; SGZ, subgranular zone.</p>
</caption>
<graphic xlink:href="fnbeh-11-00171-g0004"></graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The rationale for this study is the raise in inhalant-abuse among pregnant women, which usually include solvents containing a mixture of volatile compounds, and environmental and occupational exposures consist mostly of simultaneous exposures to various solvents. Most published works described the teratogenicity due to industrial exposure to a single volatile solvent and the teratogenic potential of chemical mixture such as thinner remains under-investigated. Hence, the current study is the first attempt evaluated developmental and behavioral effects in offspring of mice prenatally exposed briefly and repeatedly to thinner. The present results showed that, despite one case of thinner induced abortion at the higher dose, prenatal exposure to the solvent did not cause any maternal toxicity nor decrease viability of the offspring. In contrast, there were significant effects on birth weight, litter size, sensory-motor development, recognition memory, anxiolytic- and depression-like behaviors independently of sex at adult age.</p>
<sec id="s4-1">
<title>Methodological Considerations</title>
<p>The present study used a pattern of brief (15 min) and repeated (two sessions of 15 min twice a day, 60 min/day in total) inhalation of different concentrations of thinner (300 or 600 ppm) during pregnancy (7 days/week for 20 days) in mice. This pattern of exposure, typically found with inhaled solvent abuse, mirrors exposure levels, administration route and exposure durations. The fetuses in this study were exposed to concentrations of thinner mimicking those attained clinically. In previous study in our lab, we have used exposure parameters identical to the present study (Fifel et al., <xref ref-type="bibr" rid="B26">2014</xref>). It was reported that depending on the solvents, the concentrations used during abuse episodes in human vary considerably and involves mostly high concentrations (up to 15,000 ppm; Hathaway and Proctor, <xref ref-type="bibr" rid="B37">2004</xref>; Bowen et al., <xref ref-type="bibr" rid="B14">2006</xref>). However, it has been demonstrated that mean solvent concentrations in the atmosphere measured in working environments in several industries (e.g., car painting, printing, fiber glass reinforced unsaturated polyester industries, and furniture industries) are in the range of 35–210 ppm (short term measurements; Dreiem et al., <xref ref-type="bibr" rid="B25">2005</xref>). This indicates that the nominal concentrations used in this study are in a range that is relevant for occupational exposure; we suggested that concentrations slightly higher than 200 ppm but largely lower than the concentrations used to mimic binge patterns will lead to teratological and developmental consequences. The most common route of exposure in the working environment is by inhalation, and since the inhalant abuse is periodic or episodic rather than continuous, repeated and brief episodes of thinner exposure (4 × 15 min/day) were used. Three reasons justify our choice of this paradigm: Firstly, the analyses by gas chromatography showed that all thinner components are evaporated during the 15 min after thinner injection. Secondly, we used a static system of solvents delivery which causes the carbon dioxide (CO<sub>2</sub>) accumulation over time (Bowen et al., <xref ref-type="bibr" rid="B14">2006</xref>). Therefore, in order to prevent potential CO<sub>2</sub> poisoning, the 30 min duration of each inhalation session was divided in 2 × 15 min separated by 5 min during which the animals were returned to their home cage where they could breathe fresh air. The third reason behind using 2 × 15 min sessions is based on epidemiological data showing that, the exposure to solvents during abuse episodes in human typically lasts a few minutes (&lt;10 min; Hathaway and Proctor, <xref ref-type="bibr" rid="B37">2004</xref>; Bowen et al., <xref ref-type="bibr" rid="B14">2006</xref>). In addition, the exposures to inhalants began on GD8 in several previous studies (Bowen et al., <xref ref-type="bibr" rid="B17">2009</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>; Callan et al., <xref ref-type="bibr" rid="B22">2015</xref>) because GD8 is post implantation and limits the risk of resorption. Since the timing of the exposure period can influence outcome, in the present animal model, the thinner exposures were performed from GD0 through GD20. This animal model, that patterns exposure to model inhalant abuse practices, will be able to assess the teratogenic potential of abused solvents with highly fidelity and sensitivity to clinical situation than other patterns.</p>
</sec>
<sec id="s4-2">
<title>Effects on Reproduction Parameters</title>
<p>The effects of thinner exposure on offspring development and behavior occurred in the absence of any obvious maternal or fetal toxicity. Despite some cases of thinner induced abortion and preterm births at the higher dose of thinner, no significant differences were observed in fertility and reproduction parameters. Previous studies of toluene exposure in rats have produced conflicting results regarding fertility and reproduction indices (Bowen et al., <xref ref-type="bibr" rid="B13">2005</xref>, <xref ref-type="bibr" rid="B17">2009</xref>; Roberts et al., <xref ref-type="bibr" rid="B61">2007</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>). A possible explanation for the discrepancies in the results of maternal and fetal toxicity may lie in the unique methodologies used by each experimenter with regard to routes of administration, exposure duration and concentration, stage of development during exposure, maternal age, and the species used. Clinically, several cases of inhalants-related embryopathy and malformations have been reported after solvents abuse by pregnant women (e.g., toluene, 1,1,1-trichlorethane and gasoline; Arai et al., <xref ref-type="bibr" rid="B6">1997</xref>; Hannigan and Bowen, <xref ref-type="bibr" rid="B34">2010</xref>; Bowen, <xref ref-type="bibr" rid="B12">2011</xref>). Individual cases of perinatal death and surviving neonates, showing evidence of morphological and functional teratogenicity (termed “Fetal Solvent Syndrome”), have been reported in children born to women exposed to very high levels of toluene during their pregnancies (Arnold et al., <xref ref-type="bibr" rid="B7">1994</xref>; Pearson et al., <xref ref-type="bibr" rid="B59">1994</xref>).</p>
<p>In the present work, the daily exposure of pregnant mice to thinner vapor during gestation reduced weight gain in dams. Moreover, although body weights and length of the thinner-prenatally treated pups did not differ from non-treated pups at birth (PND1), but showed a significant decrease in the body growth from PND1 until PND21. Several studies have suggested that the current growth restrictions could be attributed to the decreased gestational body weight and possible under-nutrition of the mother (Saillenfait et al., <xref ref-type="bibr" rid="B65">2007</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>; Callan et al., <xref ref-type="bibr" rid="B22">2015</xref>). Others have reported that fetal and placental weights regardless of maternal food consumption decreases after prenatal exposure to solvent (Gospe et al., <xref ref-type="bibr" rid="B32">1994</xref>; Gospe and Zhou, <xref ref-type="bibr" rid="B33">1998</xref>). Therefore, it is possible that inhalant exposure during pregnancy may have persistent impacts on lactation and/or maternal behavior which were insufficient for postnatal maturation of the offspring.</p>
</sec>
<sec id="s4-3">
<title>Postnatal Development of Pre-Exposed Pups</title>
<p>Following prenatal exposure to thinner, the postnatal observations showed an overall delay in the innate reflexes While there was no significant thinner-induced shift in physical maturation as evaluated by physical landmarks (i.e., pinna detachment and incisors eruption), mice offspring exposed <italic>in utero</italic> to high concentration of thinner showed significant reduction in postnatal growth up to weaning. These deficits were seen in measures of sensory-motor development and reflex ability. Pups exposed to the higher concentration of thinner exhibited delays in the righting reflex, cliff avoidance reflex and negative geotaxis reflex relative to sham-exposed pups. These results agreed with previous findings, which reported that the prenatal exposure to xylene and toluene delayed the development of those behavioral patterns (Hass et al., <xref ref-type="bibr" rid="B36">1995</xref>; Hougaard et al., <xref ref-type="bibr" rid="B40">1999</xref>; Bowen and Hannigan, <xref ref-type="bibr" rid="B16">2013</xref>). This alteration observed in reflexologic tests in the exposed pups may indicates important neural damage for righting such as vestibular function (Secher et al., <xref ref-type="bibr" rid="B70">2006</xref>), and also deficits accompanying a mouse cerebellum developmental delay (Aruga et al., <xref ref-type="bibr" rid="B8">1998</xref>). The vestibular system functions already at birth (Altman and Sudarshan, <xref ref-type="bibr" rid="B5">1975</xref>), but righting is not accomplished until after maturation of various placing and supporting reactions in the motor system. It is also noted that thinner-exposed pups displayed an altered response in homing test, which considered a test incorporates more complex measures of interest in social odors, cognitive and sensorimotor abilities (Scattoni et al., <xref ref-type="bibr" rid="B69">2008</xref>).</p>
</sec>
<sec id="s4-4">
<title>Neurobehavioral Effects on Adult Prenatally Exposed to Thinner</title>
<p>In addition to any changes in the body weight in both sexes, our data relative to performance in Rotarod test, distance moved, and moving velocity in the open-field test at PND60 showed that the animals exposed to thinner <italic>in utero</italic> did not differ from controls, indicating that both motor coordination and activity were not disturbed.</p>
<p>Interestingly, the prenatal exposure to the thinner at the used concentrations in this study induces anxiolytic- and depression-like behaviors at adulthood as assessed by different behavioral tests. These findings joined those of previous studies obtained by Bowen et al. (<xref ref-type="bibr" rid="B18">1996</xref>), Páez-Martínez et al. (<xref ref-type="bibr" rid="B57">2003</xref>) and Fifel et al. (<xref ref-type="bibr" rid="B26">2014</xref>) showing the anxiolytic properties of different solvents (thinner, toluene, benzene, 1,1,1-trichloroethane, diethyl ether and flurothyl) in exposed adult mice. At the molecular level, the anxiolytic effect of thinner is not an unexpected finding and it could be related to the ability of its components to act as positive modulators of GABAA receptors, like other CNS depressant molecules (Bale et al., <xref ref-type="bibr" rid="B9">2005</xref>; Williams et al., <xref ref-type="bibr" rid="B85">2005</xref>).</p>
<p>The results derived from the effects of prenatal thinner exposure on the offspring cognitive functions highlight impairments in executive function and memory retention at adult age, as revealed by the Puzzle box and the step-through inhibitory avoidance tests. The Puzzle box test, considered a highly reliable test of higher-order cognitive functioning (Ben Abdallah et al., <xref ref-type="bibr" rid="B10">2011</xref>), resulted in thinner 600 ppm-exposed mice exhibiting prolonged latencies to reach the goal zone relative to control mice. Moreover, the exposure <italic>in utero</italic> to 600 ppm of thinner resulted in decreased latency to enter the dark chamber calculated during step-through inhibitory avoidance test. No differences were seen between thinner 300 ppm-exposed mice and their control counterparts in the latencies of both behavioral tests. These observations are compatible with findings by Hass et al. (<xref ref-type="bibr" rid="B36">1995</xref>, <xref ref-type="bibr" rid="B35">1999</xref>) who showed that the mnemonic processes are particularly vulnerable to xylene and toluene effects. Additionally, similar results have been demonstrated by other experimental tests (i.e., the object recognition test and the Morris water maze task), which involve short-term memory or spatial learning (Fifel et al., <xref ref-type="bibr" rid="B26">2014</xref>; López-Rubalcava et al., <xref ref-type="bibr" rid="B47">2014</xref>; Callan et al., <xref ref-type="bibr" rid="B22">2015</xref>). No mechanistic studies have been designed to find out the molecular targets implicated in cognitive impairments, but changes in the expression of NMDA receptor (subunits NR1 and NR2 mRNA), NMDA receptor antagonism, and inhibition of neurogenesis in the hippocampus could be associated with the impaired memory observed in mice exposed to thinner during gestation (Seo et al., <xref ref-type="bibr" rid="B71">2010</xref>; Huerta-Rivas et al., <xref ref-type="bibr" rid="B42">2012</xref>; Win-Shwe and Fujimaki, <xref ref-type="bibr" rid="B88">2012</xref>).</p>
<p>As the DG subregion of the hippocampus is a substrate for both cognition and mood regulation (Sahay et al., <xref ref-type="bibr" rid="B64">2011</xref>), it was important to evaluate whether the prenatal exposure to thinner led to any morphological alterations in this area. Histological evidence and volumetric finding indicate that thinner may interfere with the development of the hippocampus, demonstrating by the smaller volume of the granule cell layer of the hippocampal dentate gyrus in animals exposed prenatally to 600 ppm of thinner. The finding of reduced DG volume after prenatal exposure to thinner is in accord with a study on the effects of postnatal exposure to 100 and 500 ppm toluene on the developing hippocampus in rats (12 h/day, day 1–28 postnatally; Slomianka et al., <xref ref-type="bibr" rid="B73">1990</xref>). The results of those authors, demonstrated that in addition of the smaller volume observed within the area dentate of exposed animals (granule cell layer, hilus, and the commissural-associational zone of the dentate molecular layer), argyrophilic cells and pronounced granule cell degeneration were found in the granule cell layer of animals exposed to the higher dose of toluene. The effects of early developmental thinner exposure on DG volume may be secondary to a number of indirect effects, including disrupted synaptogenesis (Lin et al., <xref ref-type="bibr" rid="B52">2009</xref>), altered expression of neurotrophic factors (e.g., nerve growth factor and brain-derived neurotrophic factor), increases in NMDA receptors (Lee et al., <xref ref-type="bibr" rid="B50">2005</xref>), pro-inflammatory cytokines and glial markers (e.g., glial fibrillary acidic protein; Win-Shwe et al., <xref ref-type="bibr" rid="B89">2012</xref>). While the behavioral alterations seen in prenatally exposed mice are consistent with hippocampal involvement, causal relationship, however, remains to be elucidated.</p>
<p>In summary, our experiments have provided several main findings to support our hypothesis that the exposure <italic>in utero</italic> to paint thinner results in behavioral, functional, and structural deficits. These alterations may be irreversible as they were apparent at adult age. Real life always involves simultaneous inhalations of multiple solvents, indicating the need for further studies, with combinations of substances, on the outcomes and mechanisms of thinner-induced developmental and behavioral effects.</p>
</sec>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>HM, MB, FMM and SB designed the experiments; HM and FMM performed the experiments; HM, MB, FMM and SB performed the analysis of the data; HM and FMM assembled the figures. HM, SB, MB and FMM wrote and edited the manuscript. All authors validated it.</p>
</sec>
<sec id="s6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This research was supported by NEUREN Project (PIRSES-GA-2012-318997). We thank A. REGRAGUI for his support by providing us experimental animals.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J.</given-names></name></person-group> (<year>1986</year>). “<article-title>Methods in behavioral teratology</article-title>,” in <source/>Handbook of Behavioral Teratology, eds <person-group person-group-type="editor"><name><surname>Riley</surname><given-names>E. P.</given-names></name><name><surname>Vorhees</surname><given-names>C. V.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Plenum Press</publisher-name>), <fpage>67</fpage>–<lpage>97</lpage>.</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group> (<year>2000</year>). <source/>Toxicological Profile for Toluene.
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>U.S. Public Health Service</publisher-name>.</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agin</surname><given-names>K.</given-names></name><name><surname>Hassanian-Moghaddam</surname><given-names>H.</given-names></name><name><surname>Shadnia</surname><given-names>S.</given-names></name><name><surname>Rahimi</surname><given-names>H. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Characteristic manifestations of acute paint thinner-intoxicated children</article-title>. <source/>Environ. Toxicol. Pharmacol.
<volume>45</volume>, <fpage>15</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2016.05.001</pub-id><pub-id pub-id-type="pmid">27235798</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait-Bali</surname><given-names>Y.</given-names></name><name><surname>Ba-M’hamed</surname><given-names>S.</given-names></name><name><surname>Bennis</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Prenatal Paraquat exposure induces neurobehavioral and cognitive changes in mice offspring</article-title>. <source/>Environ. Toxicol. Pharmacol.
<volume>48</volume>, <fpage>53</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2016.10.008</pub-id><pub-id pub-id-type="pmid">27764701</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>J.</given-names></name><name><surname>Sudarshan</surname><given-names>K.</given-names></name></person-group> (<year>1975</year>). <article-title>Postnatal development of locomotion in the laboratory rat</article-title>. <source/>Anim. Behav.
<volume>23</volume>, <fpage>896</fpage>–<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1016/0003-3472(75)90114-1</pub-id><pub-id pub-id-type="pmid">1200422</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Miyake</surname><given-names>S.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Iwamoto</surname><given-names>H.</given-names></name><name><surname>Aida</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome</article-title>. <source/>No To Hattatsu
<volume>29</volume>, <fpage>361</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="pmid">9294310</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>G. L.</given-names></name><name><surname>Kirby</surname><given-names>R. S.</given-names></name><name><surname>Langendoerfer</surname><given-names>S.</given-names></name><name><surname>Wilkins-Haug</surname><given-names>L.</given-names></name></person-group> (<year>1994</year>). <article-title>Toluene embryopathy: clinical delineation and developmental follow-up</article-title>. <source/>Pediatrics
<volume>93</volume>, <fpage>216</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="pmid">7510062</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aruga</surname><given-names>J.</given-names></name><name><surname>Minowa</surname><given-names>O.</given-names></name><name><surname>Yaginuma</surname><given-names>H.</given-names></name><name><surname>Kuno</surname><given-names>J.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Mouse Zicl is involvedin cerebellar development</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>284</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="pmid">9412507</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>A. S.</given-names></name><name><surname>Tu</surname><given-names>Y.</given-names></name><name><surname>Carpenter-Hyland</surname><given-names>E. P.</given-names></name><name><surname>Chandler</surname><given-names>L. J.</given-names></name><name><surname>Woodward</surname><given-names>J. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused solvent toluene</article-title>. <source/>Neuroscience
<volume>130</volume>, <fpage>197</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.08.040</pub-id><pub-id pub-id-type="pmid">15561435</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Abdallah</surname><given-names>N. M.</given-names></name><name><surname>Fuss</surname><given-names>J.</given-names></name><name><surname>Trusel</surname><given-names>M.</given-names></name><name><surname>Galsworthy</surname><given-names>M. J.</given-names></name><name><surname>Bobsin</surname><given-names>K.</given-names></name><name><surname>Colacicco</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia</article-title>. <source/>Exp. Neurol.
<volume>227</volume>, <fpage>42</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2010.09.008</pub-id><pub-id pub-id-type="pmid">20851119</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benignus</surname><given-names>V. A.</given-names></name></person-group> (<year>1981</year>). <article-title>Neurobehavioral effects of toluene: a review</article-title>. <source/>Neurobehav. Toxicol. Teratol.
<volume>3</volume>, <fpage>407</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="pmid">7038526</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome</article-title>. <source/>Subst. Use Misuse
<volume>46</volume>, <fpage>68</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3109/10826084.2011.580220</pub-id><pub-id pub-id-type="pmid">21609149</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Batis</surname><given-names>J. C.</given-names></name><name><surname>Mohammadi</surname><given-names>M. H.</given-names></name><name><surname>Hannigan</surname><given-names>J. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Abuse pattern of gestational toluene exposure and early postnatal development in rats</article-title>. <source/>Neurotoxicol. Teratol.
<volume>27</volume>, <fpage>105</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2004.09.007</pub-id><pub-id pub-id-type="pmid">15681125</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Batis</surname><given-names>J. C.</given-names></name><name><surname>Paez-Martinez</surname><given-names>N.</given-names></name><name><surname>Cruz</surname><given-names>S. L.</given-names></name></person-group> (<year>2006</year>). <article-title>The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies</article-title>. <source/>Neurotoxicol. Teratol.
<volume>28</volume>, <fpage>636</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2006.09.005</pub-id><pub-id pub-id-type="pmid">17064879</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Cruz</surname><given-names>S. L.</given-names></name></person-group> (<year>2012</year>). “<article-title>Inhalants: addiction and toxic effects in the human</article-title>,” in <source/>The Effects of Drug Abuse on the Human Nervous System, eds <person-group person-group-type="editor"><name><surname>Madras</surname><given-names>B.</given-names></name><name><surname>Kuhar</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>Milan</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>553</fpage>–<lpage>574</lpage>.</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Hannigan</surname><given-names>J. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Binge toluene exposure in pregnancy and pre-weaning developmental consequences in rats</article-title>. <source/>Neurotoxicol. Teratol.
<volume>38</volume>, <fpage>29</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2013.04.002</pub-id><pub-id pub-id-type="pmid">23597557</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Irtenkauf</surname><given-names>S.</given-names></name><name><surname>Hannigan</surname><given-names>J. H.</given-names></name><name><surname>Stefanski</surname><given-names>A. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Alterations in rat fetal morphology following abuse patterns of toluene exposure</article-title>. <source/>Reprod. Toxicol.
<volume>27</volume>, <fpage>161</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2009.01.002</pub-id><pub-id pub-id-type="pmid">19429395</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Wiley</surname><given-names>J. L.</given-names></name><name><surname>Balster</surname><given-names>R. L.</given-names></name></person-group> (<year>1996</year>). <article-title>The effects of abused inhalants on mouse behavior in an elevated plus-maze</article-title>. <source/>Eur. J. Pharmacol.
<volume>312</volume>, <fpage>131</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(96)00459-1</pub-id><pub-id pub-id-type="pmid">8894586</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brozosky</surname><given-names>M.</given-names></name><name><surname>Winkler</surname><given-names>E. G.</given-names></name></person-group> (<year>1965</year>). <article-title>Glue sniffing in children and adolescents</article-title>. <source/>N Y State Med. J.
<volume>65</volume>, <fpage>1984</fpage>–<lpage>1989</lpage>.</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukowski</surname><given-names>J. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Review of the epidemiological evidence relating toluene to reproductive outcomes</article-title>. <source/>Regul. Toxicol. Pharmacol.
<volume>33</volume>, <fpage>147</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1006/rtph.2000.1448</pub-id><pub-id pub-id-type="pmid">11350197</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butland</surname><given-names>B. K.</given-names></name><name><surname>Field-Smith</surname><given-names>M. E.</given-names></name><name><surname>Ramsey</surname><given-names>J. D.</given-names></name><name><surname>Anderson</surname><given-names>H. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme</article-title>. <source/>Addiction
<volume>108</volume>, <fpage>385</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2012.04047.x</pub-id><pub-id pub-id-type="pmid">22882771</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callan</surname><given-names>S. P.</given-names></name><name><surname>Hannigan</surname><given-names>J. H.</given-names></name><name><surname>Bowen</surname><given-names>S. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Prenatal toluene exposure impairs performance in the Morris Water Maze in adolescent rats</article-title>. <source/>Neuroscience
<volume>342</volume>, <fpage>180</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.08.050</pub-id><pub-id pub-id-type="pmid">26318334</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>S. L.</given-names></name></person-group> (<year>2011</year>). <article-title>The latest evidence in the neuroscience of solvent misuse: an article written for service providers</article-title>. <source/>Subst. Use Misuse
<volume>46</volume>, <fpage>62</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.3109/10826084.2011.580215</pub-id><pub-id pub-id-type="pmid">21609148</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donald</surname><given-names>J. M.</given-names></name><name><surname>Hooper</surname><given-names>K.</given-names></name><name><surname>Hopenhayn-Rich</surname><given-names>C.</given-names></name></person-group> (<year>1991</year>). <article-title>Reproductive and developmental toxicity of toluene: a review</article-title>. <source/>Environ. Health Perspect.
<volume>94</volume>, <fpage>237</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.2307/3431317</pub-id><pub-id pub-id-type="pmid">1954933</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreiem</surname><given-names>A.</given-names></name><name><surname>Ring</surname><given-names>A.</given-names></name><name><surname>Fonnum</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Organic solvent-induced cell death in rat cerebellar granule cells: structure dependence of c10 hydrocarbons and relationship to reactive oxygen species formation</article-title>. <source/>Neurotoxicology
<volume>26</volume>, <fpage>321</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2005.01.006</pub-id><pub-id pub-id-type="pmid">15935204</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fifel</surname><given-names>K.</given-names></name><name><surname>Bennis</surname><given-names>M.</given-names></name><name><surname>Ba-M’hamed</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of acute and chronic inhalation of paint thinner in mice: behavioral and immunohistochemical study</article-title>. <source/>Metab. Brain Dis.
<volume>29</volume>, <fpage>471</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-013-9449-4</pub-id><pub-id pub-id-type="pmid">24218105</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filley</surname><given-names>C. M.</given-names></name><name><surname>Halliday</surname><given-names>W.</given-names></name><name><surname>Kleinschmidt-DeMasters</surname><given-names>B. K.</given-names></name></person-group> (<year>2004</year>). <article-title>The effects of toluene on the central nervous system</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>63</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/63.1.1</pub-id><pub-id pub-id-type="pmid">14748556</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornazzari</surname><given-names>L.</given-names></name><name><surname>Wilkinson</surname><given-names>D. A.</given-names></name><name><surname>Kapur</surname><given-names>B. M.</given-names></name><name><surname>Carlen</surname><given-names>P. L.</given-names></name></person-group> (<year>1983</year>). <article-title>Cerebellar, cortical and functional impairment in toluene abusers</article-title>. <source/>Acta Neurol. Scand.
<volume>67</volume>, <fpage>319</fpage>–<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.1983.tb03149.x</pub-id><pub-id pub-id-type="pmid">6613519</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>W. M.</given-names></name></person-group> (<year>1965</year>). <article-title>Reflex and behavioural development of the mouse</article-title>. <source/>Anim. Behav.
<volume>13</volume>, <fpage>234</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/0003-3472(65)90041-2</pub-id><pub-id pub-id-type="pmid">5835840</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghantous</surname><given-names>H.</given-names></name><name><surname>Danielsson</surname><given-names>B. R. G.</given-names></name></person-group> (<year>1986</year>). <article-title>Placental transfer and distribution of toluene, xylene and benzene and their active metabolites during gestation in mice</article-title>. <source/>Biol. Res. Pregnancy Perinatol.
<volume>7</volume>, <fpage>98</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">3778990</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>T. M.</given-names></name></person-group> (<year>1988</year>). <article-title>Toluene abuse and renal tubular acidosis in pregnancy</article-title>. <source/>Obstet. Gynecol.
<volume>71</volume>, <fpage>715</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="pmid">3357661</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gospe</surname><given-names>S. M.</given-names><suffix>Jr.</suffix></name><name><surname>Saeed</surname><given-names>D. B.</given-names></name><name><surname>Zhou</surname><given-names>S. S.</given-names></name><name><surname>Zeman</surname><given-names>F. J.</given-names></name></person-group> (<year>1994</year>). <article-title>The effects of high-dose toluene on embryonic development in the rat</article-title>. <source/>Pediatr. Res.
<volume>36</volume>, <fpage>811</fpage>–<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199412000-00023</pub-id><pub-id pub-id-type="pmid">7898990</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gospe</surname><given-names>S. M.</given-names><suffix>Jr.</suffix></name><name><surname>Zhou</surname><given-names>S. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats</article-title>. <source/>Reprod. Toxicol.
<volume>12</volume>, <fpage>119</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/s0890-6238(97)00128-7</pub-id><pub-id pub-id-type="pmid">9535505</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannigan</surname><given-names>J. H.</given-names></name><name><surname>Bowen</surname><given-names>S. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Reproductive toxicology and teratology of abused toluene</article-title>. <source/>Syst. Biol. Reprod. Med.
<volume>56</volume>, <fpage>184</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.3109/19396360903377195</pub-id><pub-id pub-id-type="pmid">20377315</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hass</surname><given-names>U.</given-names></name><name><surname>Lund</surname><given-names>S. P.</given-names></name><name><surname>Hougaard</surname><given-names>K. S.</given-names></name><name><surname>Simonsen</surname><given-names>L.</given-names></name></person-group> (<year>1999</year>). <article-title>Developmental neurotoxicity after toluene inhalation exposure in rats</article-title>. <source/>Neurotoxicol. Teratol.
<volume>21</volume>, <fpage>349</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/s0892-0362(99)00013-6</pub-id><pub-id pub-id-type="pmid">10440478</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hass</surname><given-names>U.</given-names></name><name><surname>Lund</surname><given-names>S. P.</given-names></name><name><surname>Simonsen</surname><given-names>L.</given-names></name><name><surname>Fries</surname><given-names>A. S.</given-names></name></person-group> (<year>1995</year>). <article-title>Effects of prenatal exposure to xylene on postnatal development and behavior in rats</article-title>. <source/>Neurotoxicol. Teratol.
<volume>17</volume>, <fpage>341</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/0892-0362(94)00093-s</pub-id><pub-id pub-id-type="pmid">7623741</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hathaway</surname><given-names>G. J.</given-names></name><name><surname>Proctor</surname><given-names>N. H.</given-names></name></person-group> (<year>2004</year>). “<article-title>Toluene</article-title>,” in <source/>Proctor and Hughes’ Chemical Hazards of the Workplace, <edition>5th Edn.</edition> eds <person-group person-group-type="editor"><name><surname>Hathaway</surname><given-names>G. J.</given-names></name><name><surname>Proctor</surname><given-names>N. H.</given-names></name></person-group> (<publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley &amp; Sons</publisher-name>), <fpage>681</fpage>–<lpage>682</lpage>.</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersh</surname><given-names>J. H.</given-names></name></person-group> (<year>1989</year>). <article-title>Toluene embryopathy: two new cases</article-title>. <source/>J. Med. Genet.
<volume>26</volume>, <fpage>333</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.26.5.333</pub-id><pub-id pub-id-type="pmid">2471833</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersh</surname><given-names>J. H.</given-names></name><name><surname>Podruch</surname><given-names>P. E.</given-names></name><name><surname>Rogers</surname><given-names>G.</given-names></name><name><surname>Weisskopf</surname><given-names>B.</given-names></name></person-group> (<year>1985</year>). <article-title>Toluene embryopathy</article-title>. <source/>J. Pediatr.
<volume>106</volume>, <fpage>922</fpage>–<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(85)80238-9</pub-id><pub-id pub-id-type="pmid">4039753</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hougaard</surname><given-names>K. S.</given-names></name><name><surname>Hass</surname><given-names>U.</given-names></name><name><surname>Lund</surname><given-names>S. P.</given-names></name><name><surname>Simonsen</surname><given-names>L.</given-names></name></person-group> (<year>1999</year>). <article-title>Effects of prenatal exposure to toluene on postnatal development and behavior in rats</article-title>. <source/>Neurotoxicol. Teratol.
<volume>21</volume>, <fpage>241</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/s0892-0362(98)00053-1</pub-id><pub-id pub-id-type="pmid">10386827</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>M. O.</given-names></name><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Garland</surname><given-names>E. L.</given-names></name><name><surname>Perron</surname><given-names>B. E.</given-names></name><name><surname>Vaughn</surname><given-names>M. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Inhalant use and inhalant use disorders in the United States</article-title>. <source/>Addict. Sci. Clin. Pract.
<volume>6</volume>, <fpage>18</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="pmid">22003419</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huerta-Rivas</surname><given-names>A.</given-names></name><name><surname>López-Rubalcava</surname><given-names>C.</given-names></name><name><surname>Sćanchez-Serrano</surname><given-names>S. L.</given-names></name><name><surname>Valdez-Tapia</surname><given-names>M.</given-names></name><name><surname>Lamas</surname><given-names>M.</given-names></name><name><surname>Cruz</surname><given-names>S. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Toluene impairs learning and memory, has antinociceptive effects and modifies histone acetylation in the dentate gyrus of adolescent and adult rats</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>102</volume>, <fpage>48</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2012.03.018</pub-id><pub-id pub-id-type="pmid">22497993</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>A. G.</given-names></name><name><surname>Thompson</surname><given-names>D.</given-names></name><name><surname>Evans</surname><given-names>J. A.</given-names></name></person-group> (<year>1979</year>). <article-title>Is there a fetal gasoline syndrome?</article-title>
<source/>Teratology
<volume>20</volume>, <fpage>75</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1002/tera.1420200111</pub-id><pub-id pub-id-type="pmid">515965</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isingrini</surname><given-names>E.</given-names></name><name><surname>Camus</surname><given-names>V.</given-names></name><name><surname>Le Guisquet</surname><given-names>A. M.</given-names></name><name><surname>Pingaud</surname><given-names>M.</given-names></name><name><surname>Devers</surname><given-names>S.</given-names></name><name><surname>Belzung</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a modelof fluoxetine resistance in mice</article-title>. <source/>PLoS One
<volume>5</volume>:<fpage>10404</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010404</pub-id><pub-id pub-id-type="pmid">20436931</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamran</surname><given-names>S.</given-names></name><name><surname>Bakshi</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images</article-title>. <source/>Neuroradiology
<volume>40</volume>, <fpage>519</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1007/s002340050637</pub-id><pub-id pub-id-type="pmid">9763341</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname><given-names>R.</given-names></name><name><surname>Harabuchi</surname><given-names>I.</given-names></name><name><surname>Katakura</surname><given-names>Y.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Miyake</surname><given-names>H.</given-names></name></person-group> (<year>1993</year>). <article-title>Neurobehavioral effects of chronic occupational exposure to organic solvents among Japanese industrial painters</article-title>. <source/>Environ. Res.
<volume>62</volume>, <fpage>303</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1006/enrs.1993.1115</pub-id><pub-id pub-id-type="pmid">8344237</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapiz-Bluhm</surname><given-names>M. D. S.</given-names></name><name><surname>Bondi</surname><given-names>C. O.</given-names></name><name><surname>Doyen</surname><given-names>J.</given-names></name><name><surname>Rodriguez</surname><given-names>G. A.</given-names></name><name><surname>Bédard-Arana</surname><given-names>T.</given-names></name><name><surname>Morilak</surname><given-names>D. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Behavioural assays to model cognitive and affectivedimensions of depression and anxiety in rats</article-title>. <source/>J. Neuroendocrinol.
<volume>20</volume>, <fpage>1115</fpage>–<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01772.x</pub-id><pub-id pub-id-type="pmid">18673411</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Rubalcava</surname><given-names>C.</given-names></name><name><surname>Chávez-Alvarez</surname><given-names>K.</given-names></name><name><surname>Huerta-Rivas</surname><given-names>A. G.</given-names></name><name><surname>Páez-Martínez</surname><given-names>N.</given-names></name><name><surname>Bowen</surname><given-names>S. E.</given-names></name><name><surname>Cruz</surname><given-names>S. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Long-term behavioral consequences of prenatal binge toluene</article-title>. <source/>J. Drug Alcohol Res.
<volume>3</volume>:<fpage>235841</fpage>
<pub-id pub-id-type="doi">10.4303/jdar/235841</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazar</surname><given-names>R. B.</given-names></name><name><surname>Ho</surname><given-names>S. U.</given-names></name><name><surname>Melen</surname><given-names>O.</given-names></name><name><surname>Daghestani</surname><given-names>A. N.</given-names></name></person-group> (<year>1983</year>). <article-title>Multifocal central nervous system damage caused by toluene abuse</article-title>. <source/>Neurology
<volume>33</volume>, <fpage>1337</fpage>–<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.33.10.1337</pub-id><pub-id pub-id-type="pmid">6684230</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. F.</given-names></name><name><surname>Lo</surname><given-names>P. S.</given-names></name><name><surname>Wang</surname><given-names>Y. J.</given-names></name><name><surname>Hu</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>H. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Neonatal toluene exposure alters N-methyl-D-aspartate receptor subunit expression in the hippocampus and cerebellum in juvenile rats</article-title>. <source/>Neuropharmacology
<volume>48</volume>, <fpage>195</fpage>–<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.09.008</pub-id><pub-id pub-id-type="pmid">15695158</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. L.</given-names></name><name><surname>Pai</surname><given-names>M. C.</given-names></name><name><surname>Chen</surname><given-names>J. H.</given-names></name><name><surname>Guo</surname><given-names>Y. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Central neurological abnormalities and multiple chemical sensitivity caused by chronic toluene exposure</article-title>. <source/>Occup. Med. (Lond)
<volume>53</volume>, <fpage>479</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1093/occmed/kqg095</pub-id><pub-id pub-id-type="pmid">14581647</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Jow</surname><given-names>G.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Toluene disrupts synaptogenesis in cultured hippocampal neurons</article-title>. <source/>Toxicol. Lett.
<volume>184</volume>, <fpage>90</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2008.10.027</pub-id><pub-id pub-id-type="pmid">19038319</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>P. S.</given-names></name><name><surname>Wu</surname><given-names>C. Y.</given-names></name><name><surname>Sue</surname><given-names>H. Z.</given-names></name><name><surname>Chen</surname><given-names>H. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors</article-title>. <source/>Toxicology
<volume>265</volume>, <fpage>34</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2009.09.005</pub-id><pub-id pub-id-type="pmid">19765629</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>V. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Neurobehavioral screening in rodents</article-title>. <source/>Curr. Protoc. Toxicol. Chapter <volume>11</volume>:<fpage>Unit11.2</fpage>. <pub-id pub-id-type="doi">10.1002/0471140856.tx1102s06</pub-id><pub-id pub-id-type="pmid">20957639</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>T. P.</given-names></name><name><surname>Foo</surname><given-names>S. C.</given-names></name><name><surname>Yoong</surname><given-names>T.</given-names></name></person-group> (<year>1992</year>). <article-title>Risk of spontaneous abortion in workers exposed to toluene</article-title>. <source/>Br. J. Ind. Med.
<volume>49</volume>, <fpage>804</fpage>–<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1136/oem.49.11.804</pub-id><pub-id pub-id-type="pmid">1463682</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>OECD Test Guideline Programme</collab></person-group> (<year>1996</year>). <source/>Report of the OECD Consultation Meeting on Developmental Neurotoxicity. (<publisher-loc>Copenhagen, Denmark</publisher-loc>), <fpage>1</fpage>–<lpage>15</lpage>.</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Páez-Martínez</surname><given-names>N.</given-names></name><name><surname>Cruz</surname><given-names>S. L.</given-names></name><name><surname>López-Rubalcava</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Comparative study of the effects of toluene, benzene, 1,1,1-trichloroethane, diethyl ether, and flurothyl on anxiety and nociception in mice</article-title>. <source/>Toxicol. Appl. Pharmacol.
<volume>193</volume>, <fpage>9</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/s0041-008x(03)00335-1</pub-id><pub-id pub-id-type="pmid">14613712</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Lim</surname><given-names>C. S.</given-names></name><name><surname>Seo</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>C. A.</given-names></name><name><surname>Zhuo</surname><given-names>M.</given-names></name><name><surname>Kaang</surname><given-names>B. K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</article-title>. <source/>Mol. Pain
<volume>11</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/s12990-015-0026-1</pub-id><pub-id pub-id-type="pmid">25981600</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>M. A.</given-names></name><name><surname>Hoyme</surname><given-names>H. E.</given-names></name><name><surname>Seaver</surname><given-names>L. H.</given-names></name><name><surname>Rimsza</surname><given-names>M. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome</article-title>. <source/>Pediatrics
<volume>93</volume>, <fpage>211</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="pmid">7510061</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>Y.</given-names></name><name><surname>Smithson</surname><given-names>K. G.</given-names></name><name><surname>Sieck</surname><given-names>G. C.</given-names></name></person-group> (<year>1994</year>). <article-title>Application of the Cavalieri principle in volume estimation using laser confocal microscopy</article-title>. <source/>Neuroimage
<volume>1</volume>, <fpage>325</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.1994.1017</pub-id><pub-id pub-id-type="pmid">9343582</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>L. G.</given-names></name><name><surname>Nicolich</surname><given-names>M. J.</given-names></name><name><surname>Schreiner</surname><given-names>C. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Developmental and reproductive toxicity evaluation of toluene vapor in the rat II. Developmental toxicity</article-title>. <source/>Reprod. Toxicol.
<volume>23</volume>, <fpage>521</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2007.01.009</pub-id><pub-id pub-id-type="pmid">17360154</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>M. A.</given-names></name></person-group> (<year>1986</year>). <article-title>Volatile substance abuse: a review of possible long-term neurological, intellectual and psychiatric sequalae</article-title>. <source/>Br. J. Psychiatry
<volume>148</volume>, <fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.148.3.235</pub-id><pub-id pub-id-type="pmid">3013354</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <source/>Comparative Atlas of External Malformations in Laboratory Animals and Humans.
<publisher-loc>Bruxelle</publisher-loc>: <publisher-name>De Boeck Université</publisher-name>.</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahay</surname><given-names>A.</given-names></name><name><surname>Scobie</surname><given-names>K. N.</given-names></name><name><surname>Hill</surname><given-names>A. S.</given-names></name><name><surname>O’Carroll</surname><given-names>C. M.</given-names></name><name><surname>Kheirbek</surname><given-names>M. A.</given-names></name><name><surname>Burghardt</surname><given-names>N. S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation</article-title>. <source/>Nature
<volume>472</volume>, <fpage>466</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/nature09817</pub-id><pub-id pub-id-type="pmid">21460835</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saillenfait</surname><given-names>A. M.</given-names></name><name><surname>Gallissot</surname><given-names>F.</given-names></name><name><surname>Sabaté</surname><given-names>J. P.</given-names></name><name><surname>Bourges-Abella</surname><given-names>N.</given-names></name><name><surname>Muller</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Developmental toxic effects of ethylbenzene or toluene alone and in combination with butyl acetate in rats after inhalation exposure</article-title>. <source/>J. Appl. Toxicol.
<volume>27</volume>, <fpage>32</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/jat.1181</pub-id><pub-id pub-id-type="pmid">17177173</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scattoni</surname><given-names>M. L.</given-names></name><name><surname>Gandhy</surname><given-names>S. U.</given-names></name><name><surname>Ricceri</surname><given-names>L.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism</article-title>. <source/>PLoS One
<volume>3</volume>:<fpage>e3067</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0003067</pub-id><pub-id pub-id-type="pmid">18728777</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Secher</surname><given-names>T.</given-names></name><name><surname>Novitskaiaa</surname><given-names>V.</given-names></name><name><surname>Berezina</surname><given-names>V.</given-names></name><name><surname>Bocka</surname><given-names>E.</given-names></name><name><surname>Glenthøjb</surname><given-names>B.</given-names></name><name><surname>Klementieva</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention</article-title>. <source/>Neuroscience
<volume>141</volume>, <fpage>1289</fpage>–<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.04.059</pub-id><pub-id pub-id-type="pmid">16784819</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>H. S.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>M. S.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Kim</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Toluene inhibits hippocampal neurogenesis in adult mice</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>94</volume>, <fpage>588</fpage>–<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2009.11.015</pub-id><pub-id pub-id-type="pmid">19969016</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Vinayagam</surname><given-names>S.</given-names></name><name><surname>Vajifdar</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Methemoglobinemia as a result of accidental lacquer thinner poisoning</article-title>. <source/>Indian J. Crit. Care Med.
<volume>16</volume>, <fpage>44</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.4103/0972-5229.94435</pub-id><pub-id pub-id-type="pmid">22557834</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slomianka</surname><given-names>L.</given-names></name><name><surname>Edelfors</surname><given-names>S.</given-names></name><name><surname>Ravn-Jonsen</surname><given-names>A.</given-names></name><name><surname>Rungby</surname><given-names>J.</given-names></name><name><surname>Danscher</surname><given-names>G.</given-names></name><name><surname>West</surname><given-names>M. J.</given-names></name></person-group> (<year>1990</year>). <article-title>The effect of low-level toluene exposure on the developing hippocampal region of the rat: histological evidence and volumetric findings</article-title>. <source/>Toxicology
<volume>62</volume>, <fpage>189</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/0300-483x(90)90109-t</pub-id><pub-id pub-id-type="pmid">1693795</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solak</surname><given-names>I.</given-names></name><name><surname>Cankayali</surname><given-names>I.</given-names></name><name><surname>Aksu</surname><given-names>H.</given-names></name><name><surname>Moral</surname><given-names>A. R.</given-names></name></person-group> (<year>2006</year>). <article-title>An interesting thinner intoxication case: intrathoracic injection</article-title>. <source/>Adv. Ther.
<volume>23</volume>, <fpage>502</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1007/bf02850172</pub-id><pub-id pub-id-type="pmid">16912033</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steru</surname><given-names>L.</given-names></name><name><surname>Chermat</surname><given-names>R.</given-names></name><name><surname>Thierry</surname><given-names>B.</given-names></name><name><surname>Simon</surname><given-names>P.</given-names></name></person-group> (<year>1985</year>). <article-title>The tail suspension test: a new method for screening antidepressants in mice</article-title>. <source/>Psychopharmacology (Berl)
<volume>85</volume>, <fpage>367</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1007/bf00428203</pub-id><pub-id pub-id-type="pmid">3923523</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Substance Abuse and Mental Health Services Administration</collab></person-group> (<year>2007</year>). <source/>Patterns and Trends in Inhalant Use by Adolescent Males and Females: 2002–2005.
<publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>United States Department of Health and Human Services, Substance Abuse and Mental Health Administration</publisher-name>. No. NSDUH07–0315.</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Substance Abuse and Mental Health Services Administration</collab></person-group> (<year>2011</year>). <source/>Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings.
<publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Substance Abuse and Mental Health Services Administration</publisher-name>. NSDUH Series H-41, HHS Publication No (SMA) 11–4658.</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Substance Abuse and Mental Health Services Administration</collab></person-group> (<year>2014</year>). <source/>Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings.
<publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Substance Abuse and Mental Health Services Administration</publisher-name>. NSDUH Series H-48, HHS Publication No. (SMA) 14–4863.</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>C.</given-names></name><name><surname>Escarabajal</surname><given-names>M. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Validation of a behavioral recording automated system in the elevated plus-maze test</article-title>. <source/>Life Sci.
<volume>70</volume>, <fpage>1751</fpage>–<lpage>1762</lpage>. <pub-id pub-id-type="doi">10.1016/s0024-3205(02)01476-5</pub-id><pub-id pub-id-type="pmid">12002520</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toutant</surname><given-names>C.</given-names></name><name><surname>Lippmann</surname><given-names>S.</given-names></name></person-group> (<year>1979</year>). <article-title>Fetal solvents syndrome</article-title>. <source/>Lancet
<volume>1</volume>:<fpage>1356</fpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(79)91997-4</pub-id><pub-id pub-id-type="pmid">87825</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaglenova</surname><given-names>J.</given-names></name><name><surname>Parameshwaran</surname><given-names>K.</given-names></name><name><surname>Suppiramaniam</surname><given-names>V.</given-names></name><name><surname>Breese</surname><given-names>C. R.</given-names></name><name><surname>Pandiella</surname><given-names>N.</given-names></name><name><surname>Birru</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Long-lasting teratogenic effects of nicotine on cognition: gender specificity and role of ampa receptor function</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>90</volume>, <fpage>527</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2008.06.009</pub-id><pub-id pub-id-type="pmid">18662793</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Gomber</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Thinner intoxication manifesting as methemoglobinemia</article-title>. <source/>Indian J. Pediatr.
<volume>76</volume>, <fpage>315</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1007/s12098-009-0059-4</pub-id><pub-id pub-id-type="pmid">19347673</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>G.</given-names></name><name><surname>Ögren</surname><given-names>S.-O.</given-names></name><name><surname>Li</surname><given-names>X. M.</given-names></name><name><surname>Fuxe</surname><given-names>K.</given-names></name><name><surname>Gustafsson</surname><given-names>J. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine-mediated locomotor activity and dopamine D2 agonist binding in the rat</article-title>. <source/>Toxicology
<volume>19</volume>, <fpage>223</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/0300-483x(93)90162-l</pub-id><pub-id pub-id-type="pmid">8096348</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>M.</given-names></name><name><surname>Pham</surname><given-names>T. M.</given-names></name><name><surname>Hillefors</surname><given-names>M.</given-names></name><name><surname>Bjelke</surname><given-names>B.</given-names></name><name><surname>Henriksson</surname><given-names>B.</given-names></name><name><surname>von Euler</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat</article-title>. <source/>Exp. Neurol.
<volume>163</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.1999.7288</pub-id><pub-id pub-id-type="pmid">10785438</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J. D.</given-names></name><name><surname>Chen</surname><given-names>J. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Acute and chronic neurological symptoms among paint workers exposed to mixtures of organic solvents</article-title>. <source/>Environ. Res.
<volume>61</volume>, <fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1006/enrs.1993.1054</pub-id><pub-id pub-id-type="pmid">8472664</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkins-Haug</surname><given-names>L.</given-names></name><name><surname>Gabow</surname><given-names>P. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Toluene abuse during pregnancy: obstetric complications and perinatal outcomes</article-title>. <source/>Obstet. Gynecol.
<volume>77</volume>, <fpage>504</fpage>–<lpage>509</lpage>. <pub-id pub-id-type="pmid">2002970</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J. M.</given-names></name><name><surname>Stafford</surname><given-names>D.</given-names></name><name><surname>Steketee</surname><given-names>J. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Effects of repeated inhalation of toluene on ionotropic GABAA and glutamate receptor subunit levels in rat brain</article-title>. <source/>Neurochem. Int.
<volume>46</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2004.07.006</pub-id><pub-id pub-id-type="pmid">15567510</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J. F.</given-names></name><name><surname>Storck</surname><given-names>M.</given-names></name><collab>Committee on Substance Abuse</collab><collab>Committee on Native American Child Health</collab></person-group> (<year>2007</year>). <article-title>Inhalant abuse</article-title>. <source/>Pediatrics
<volume>119</volume>, <fpage>1009</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2007-0470</pub-id><pub-id pub-id-type="pmid">17473104</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willner</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS</article-title>. <source/>Neuropsychobiology
<volume>52</volume>, <fpage>90</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1159/000087097</pub-id><pub-id pub-id-type="pmid">16037678</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R. C.</given-names></name><name><surname>Vacek</surname><given-names>T.</given-names></name><name><surname>Lanier</surname><given-names>D. L.</given-names></name><name><surname>Dewsbury</surname><given-names>D. A.</given-names></name></person-group> (<year>1976</year>). <article-title>Open-field behavior inmuroid rodents</article-title>. <source/>Behav. Biol.
<volume>17</volume>, <fpage>495</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/s0091-6773(76)90901-9</pub-id><pub-id pub-id-type="pmid">788698</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Win-Shwe</surname><given-names>T. T.</given-names></name><name><surname>Fujimaki</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Acute administration of toluene affects memory retention in novel object recognition test and memory function-related gene expression in mice</article-title>. <source/>J. Appl. Toxicol.
<volume>32</volume>, <fpage>300</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1002/jat.1693</pub-id><pub-id pub-id-type="pmid">21607994</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Win-Shwe</surname><given-names>T. T.</given-names></name><name><surname>Kunugita</surname><given-names>N.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Nakajima</surname><given-names>D.</given-names></name><name><surname>Tsukahara</surname><given-names>S.</given-names></name><name><surname>Fujimaki</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Differential mRNA expression of neuroimmune markers in the hippocampus of infant mice following toluene exposure during brain developmental period</article-title>. <source/>J. Appl. Toxicol.
<volume>32</volume>, <fpage>126</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1002/jat.1643</pub-id><pub-id pub-id-type="pmid">21381054</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>B.</given-names></name><name><surname>Kutlu</surname><given-names>S.</given-names></name><name><surname>Canpolat</surname><given-names>S.</given-names></name><name><surname>Sandal</surname><given-names>S.</given-names></name><name><surname>Ayar</surname><given-names>A.</given-names></name><name><surname>Mogulkoc</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Effects of paint thinner exposure on serum LH, FSH and testosterone levels and hypothalamic catecholamine contents in the male rat</article-title>. <source/>Biol. Pharm. Bull.
<volume>24</volume>, <fpage>163</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.24.163</pub-id><pub-id pub-id-type="pmid">11217085</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zur</surname><given-names>J.</given-names></name><name><surname>Yule</surname><given-names>W.</given-names></name></person-group> (<year>1990</year>). <article-title>Chronic solvent abuse. 1. cognitive sequelae</article-title>. <source/>Child Care Health Dev.
<volume>16</volume>, <fpage>1</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2214.1990.tb00635.x</pub-id><pub-id pub-id-type="pmid">2311197</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>